today EAO Annual Scientific Meeting Geneva Sept. 29–Oct. 1, 2022

today EAO Annual Scientific Meeting Geneva Sept. 29–Oct. 1, 2022

EAO congress makes comeback in novel hybrid format / BioHorizons Camlog organises comprehensive educational programme for EAO 2022 congress attendees / “We are planning to make quite an impact at the EAO congress” / First hybrid edition of EAO congress is critically evaluating technological developments in dentistry / News / Interview: “Innovation in education and enablement is a continuous journey” / Interview: CleanImplant Foundation: Greater safety in implantology and a stage for quality manufacturers / Interview: “Clinicians buy too many products and cannot necessarily make use of all of them” / News / Interview: “At Neoss, we have the luxury of being able to be more forward-oriented” / News / Industry / Floor plan / Exhibitors / Travel

Open PDF View E-paper Edit Epaper Edit Epaper ads save

Table of contents

) [32] => Array ( [image_url] => Array ( [2000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85785-19ed19cb/2000/page-31.jpg [1000] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85785-19ed19cb/1000/page-31.jpg [200] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85785-19ed19cb/200/page-31.jpg ) [key] => Array ( [2000] => 85785-19ed19cb/2000/page-31.jpg [1000] => 85785-19ed19cb/1000/page-31.jpg [200] => 85785-19ed19cb/200/page-31.jpg ) [ads] => Array ( [0] => Array ( [post_data] => WP_Post Object ( [ID] => 85794 [post_author] => 0 [post_date] => 2024-12-18 08:30:02 [post_date_gmt] => 2024-12-18 08:30:02 [post_content] => [post_title] => epaper-85785-page-32-ad-85794 [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => epaper-85785-page-32-ad-85794 [to_ping] => [pinged] => [post_modified] => 2024-12-18 08:30:02 [post_modified_gmt] => 2024-12-18 08:30:02 [post_content_filtered] => [post_parent] => 0 [guid] => https://e.dental-tribune.com/ad/epaper-85785-page-32-ad/ [menu_order] => 0 [post_type] => ad [post_mime_type] => [comment_count] => 0 [filter] => raw ) [id] => 85794 [id_hash] => 1ed70a888f5ed213fd9a474e59546fafbed4e9b6cc7b0fd607cd248491d8ef94 [post_type] => ad [post_date] => 2024-12-18 08:30:02 [fields] => Array ( [url] => https://www.dental-tribune.com/c/camlog/ [link] => URL ) [permalink] => https://e.dental-tribune.com/ad/epaper-85785-page-32-ad-85794/ [post_title] => epaper-85785-page-32-ad-85794 [post_status] => publish [position] => 0.31347962382445,0.43763676148796,99.059561128527,99.124726477024 [belongs_to_epaper] => 85785 [page] => 32 [cached] => false ) ) [html_content] =>

Open Link

) ) [pdf_filetime] => 1734510602 [s3_key] => 85785-19ed19cb [pdf] => today EAO Geneva 29.9.-1.10.22.pdf [pdf_location_url] => https://e.dental-tribune.com/tmp/dental-tribune-com/85785/today EAO Geneva 29.9.-1.10.22.pdf [pdf_location_local] => /var/www/vhosts/e.dental-tribune.com/httpdocs/tmp/dental-tribune-com/85785/today EAO Geneva 29.9.-1.10.22.pdf [should_regen_pages] => 1 [pdf_url] => https://epaper-dental-tribune.s3.eu-central-1.amazonaws.com/85785-19ed19cb/epaper.pdf [pages_text] => Array ( [1] =>

29 th EAO Annual Scientific Meeting • Geneva • 29 September–1 October 2022
Interview

News

Products

Dr Daniela Felipucci talks about how Straumann
meets the needs for dental education and the
company’s focus at this year’s EAO congress.

No more expired stock: New innovations are
streamlining the use of dental implants in the
age of digital dentistry.

The 2022 EAO congress offers the opportunity
to see and try out the most current innovations
in implant dentistry.

» page 8

» page 12–13

» page 22

EAO congress makes comeback in novel hybrid format
The 29th edition of the meeting returns as in-person event

Under the theme “Uniting nations
through innovations”, the 2022 EAO
congress is seeking to shine a spotlight on the role of new technology
in disrupting the way the dental profession communicates, works and
learns. The colourful EAO scientific
programme includes virtual human
technology outside of dentistry and
medicine, innovations for treatment
planning and communication, what
clinicians have learned in 30 years
of implant dentistry, and patientoriented topics, such as a session

on how to treat and handle unhappy
patients. There will also be a live
surgical session on hard-tissue regeneration with the support of digital

tools, and wide industry participation in the form of an exhibition,
industry forums and industry handson courses.

A highlight of the congress is the
clinical video competition, featuring seven
participants who will be presenting
their clinical cases in 7-minute videos

on Friday morning. The winner will
receive the European Prize for Clinical
Video on Implant Dentistry and €1,000.
A main focus of this year’s congress is
the critical examination of investments
in novel technologies and their actual
benefits for clinicians and patients.
“All these new tools that promise to
improve quality of care while reducing
treatment costs for patients do sound
tempting, but we will ask whether all of
this can be achieved just by investing
in technology and changing the practice
structure from a conventional one to a
digital one,” said Prof. Irena Sailer, chair
of this year’s EAO congress, in an interview (read the full interview on page 4).
This is the first time in the history
of the meeting that it is being held as
a hybrid congress with a virtual programme in the evenings, similar to the
EAO Digital Days of the past two years.
The digital congress programme will be
available on the EAO online platform until
3 October. More information on the congress can be found at congress.eao.org. 

BioHorizons Camlog organises
comprehensive educational programme
for EAO 2022 congress attendees

“We are planning
to make quite an impact
at the EAO congress”

An interview with Veronica Vargas, head of global events and education at BioHorizons Camlog

An interview with Melker Nilsson, CEO at Keystone Dental

Veronica Vargas.

 As a diamond sponsor of the EAO
2022 meeting, BioHorizons Camlog
has set up a comprehensive and interactive programme for attendees. In
this interview, Veronica Vargas, head
of global events and education at
BioHorizons Camlog, discusses the
educational opportunities, among
them forums, hands-on courses and
quiz games, participants can expect
at the company’s booth (C11).
Ms Vargas, what is BioHorizons
Camlog’s main focus of participation
at this year’s EAO event?
BioHorizons Camlog supports
hundreds of high-quality educational
programmes around the world each
year. At the EAO 2022 congress, we
are striving to deliver our well-known
high standard of education—from

fundamental to complex clinical lectures. We have invited renowned experts to deliver exciting presentations
and workshops during two BioHorizons
Camlog corporate forums.
In addition, we are excited to
offer a comprehensive programme of
a mix of short lectures and hands-on
workshops on Thursday, Friday and
Saturday at our expert lounge, a dedicated area built within the BioHorizons
Camlog booth that allows visitors to
experience a more intimate environment and interact with speakers while
learning new techniques and participating in live product demonstrations
by BioHorizons Camlog professional
 page 2

 As the dental industry was gearing
up for the 2022 EAO congress, Dental
Tribune International (DTI) had the
opportunity to go behind the scenes
to learn more about one of the companies presenting during the congress,
Keystone Dental. Speaking with CEO
Melker Nilsson, DTI learned about a
recent acquisition that has fuelled the
company’s mission to bring a unique fullarch solution to the European market.

© Keystone Dental

© BioHorizons Camlog


© Samuel Borges Photography/Shutterstock.com
Photography/

 Having been held in a virtual
format for the last two years, owing
to the SARS-CoV-2 pandemic, the
annual scientific meeting of the
EAO is taking place as an in-person
event again. Over the next three
days, the 29th meeting is being held
in a hybrid format, presenting an
online evening offering too. Attendees of the congress can expect
a rich programme with plentiful
educational and networking opportunities.

Mr Nilsson, could you tell us a little
a bit about Keystone and its history,
and perhaps how it has grown and
developed since its beginnings?
Keystone was founded in 2006
by a very large, well-known US-based
 page 2



Melker Nilsson, CEO of Keystone Dental since 2019.

[2] =>

news

 page 1 “BioHorizons Camlog”
trainers. In these highly educational
hands-on sessions, visitors can spend
time with product experts. The presenters include Drs Marius Steigmann,
Debra Cohn and Marcus Beschnidt.
Questions from the audience will be
addressed at the end of each session.
BioHorizons Camlog is offering two
different corporate forums at the
congress. Can you tell us a bit more
about them?
These education sessions will take
place on Friday. The first is an in-person
forum from 13:00 to 14:00 featuring
two respected key opinion leaders:
Dr Sven-Marcus Beschnidt from Germany and Dr Ramón Gómez Meda
from Spain. Both will present their perspectives on immediate implant placement and loading with different restorative approaches featuring CONELOG
PROGRESSIVE-LINE implants. From
21:30 to 21:52, an online forum will
be held by Dr Orlando Alvarez, EAO
ambassador and renowned educator
from Chile, during which he will
share his expertise on guided surgery
with BioHorizons’ short implants.
All forums are free of charge to participants.

Dr Gómez Meda will lead a practical session on soft-tissue augmentation around implants featuring
the novel porcine acellular dermal
matrix NovoMatrix on Friday from
14:00 to 16:30.
What are some of the other highlights participants can look forward
to at your booth?
Inspired by the success of our
first expert champion challenge
games during EuroPerio10 in June in
Copenhagen in Denmark, we will be
offering a fun and interactive knowledge quiz led by Dr Andres Pascual
from Spain on Saturday.



We have a comprehensive programme for Geneva and are excited
to connect face to face with all dental
professionals attending. 

At the BioHorizons Camlog booth (C11), attendees can expect numerous educational opportunities.

Attendees also have the opportunity to
participate in two different hands-on
workshops offered by your company.

What will be the focus of each of them?
On Friday from 9:00 to 11:30,
Prof. Frank Schwarz from Germany

will give a workshop on immediate
implant placement and loading with
3D planning and guided surgery,

 page 1 “Keystone Dental”
private equity house called Warburg
Pincus. The modern history of the
company really started with our current owner, Accelmed, who acquired
the majority stake of Keystone in
2018 and very rapidly thereafter acquired Paltop, an Israeli manufacturer of dental implants which provided a high-end manufacturing
plant in Israel. Now we are manufacturing almost all of our implants in
Israel and have consequently improved our product quality.
It was after these changes that
I started as CEO in 2019. Another
recent change was the acquisition
of the Australian company Osteon
Medical which has developed some
highly innovative and, I would even
say, revolutionary prosthetic concepts to restore a full arch that we
are launching at the EAO congress for
the European market.
Through these recent acquisitions,
we have changed the trajectory and
capability for innovation of the company, putting us in a very good position. We look forward to presenting
this to the European market!
Would you be able to share more
about this unique full-arch solution?
The problem we are solving is
this: it is a relatively complex process
to restore a full arch in a completely
edentulous patient, and it is quite
time-consuming. Osteon Medical has
been able to significantly reduce the
treatment steps and time it takes to
restore a full arch and does so with a
product with much higher precision,
among other advantages, based fully
on digital technology. In addition,
I would say that the price is highly
competitive.

followed by a more challenging indication involving a simultaneous approach
with sinus elevation, lateral approach
and bone augmentation. Both approaches will showcase the CONELOG
PROGRESSIVE-LINE implants.



The Nexus Plus full-arch solution, which was developed by Osteon Medical, demonstrates a new union of translucent lifelike materials and precisionmilled titanium, engineered to be easily interchangeable.

Even though this technology has
been around for almost three years
and it’s known in Australia, its widely
unknown in important markets such
as Europe and North America—except
for a few European dentists. So, the
reason why we acquired this company is to drive it in a new direction
and to promote the solution in order
to bring it to more markets. Several
articles on this new technology are
already available and have been published in different journals.

Our overall focus lies on rehabilitation with dental implants, and we
offer products in five categories: dental implants, abutments, prosthetic
solutions, biomaterials and now also
full-arch restoration from a prosthetic
point of view.

We are planning to make quite an
impact at the EAO congress with our
exhibition and an industry forum on
Saturday (from 12:45 to 13:45) with
a leading German dentist, Dr Henriette
Lerner, during which we will focus
on our new technology for full-arch
restorations.

In addition to this, mainly in
North America up until now, we offer
the associated technology that supports clinicians. For example, if you
want to work in an efficient way with
our new solution, you need an intraoral scanner and you might want to
include a printer. We offer this service of being a one-stop shop for our
customers for the entire digital workflow of our newly acquired solution.
For the European market, this technology is also often offered by our
distributors.

Let’s also talk about, more generally,
the Keystone product portfolio. What
does your company offer, and what
are some of the greatest benefits of
your company’s products for clinicians and their patients?

What can Keystone customers look
forward to in the future?
Between now and the end of the
first quarter in 2023, we will be
launching over 500 new products.
We have invested a lot to significantly

29 th EAO Annual Scientific Meeting · Geneva

increase our innovation pipeline and
are continuing our international expansion into Europe with direct sales
organisations, in selected markets.

Editorial note: More information about BioHorizons
Camlog can be found at www.biohorizonscamlog.com.
The company is showcasing its products at Booth C11.

Moreover, we are arranging six
international conferences between
March and November: in Newport
Beach, Chicago and Boston in the US,
Toronto in Canada, Melbourne in
Australia, and Athens in Greece. Our
global symposium, which we held this
year in Las Vegas in the US, will return in 2024. We launched the Nexus
solution on the North American market during this year’s global symposium and it’s fair to say that it has
been a sensation. For next June, we
are organising courses on full-arch rehabilitation, for example, in conjunction
with the University of Zurich. In addition, we are planning to offer courses
in Germany in the first quarter of
2023. 
Editorial note: More information about Keystone
Dental can be found at keystonedental.com. EAO
congress participants can learn more about the
company’s full-arch restoration at Booth F47.

about the publisher

Publisher and Chief Executive Officer
Torsten R. Oemus
Chief Content Officer
Claudia Duschek
Editors
Franziska Beier
Jeremy Booth
Brendan Day
Anisha Hall Hoppe
Iveta Ramonaite
Copy Editors
Ann-Katrin Paulick
Sabrina Raaff
Designer
Franziska Schmid
Production Executive
Gernot Meyer
Advertising Disposition
Marius Mezger

Dental Tribune International GmbH
Holbeinstraße 29 · 04229 Leipzig · Germany
Tel.: +49 341 48474-302
Fax: +49 341 48474-173
General requests: info@dental-tribune.com
Sales requests: mediasales@dental-tribune.com
www.dental-tribune.com
today will appear at the 29th annual scientific meeting of the European Association for Osseointegration in Geneve in Switzerland,
29 September–1 October 2022. The newspaper and materials
therein are copyrighted by Dental Tribune International GmbH.
Dental Tribune International GmbH makes every effort to report
clinical information and manufacturers’ product news accurately
but cannot assume responsibility for the validity of product claims
or for typographical errors. The publisher also does not assume
responsibility for product names, claims or statements made by
advertisers. Opinions expressed by authors are their own and may
not reflect those of Dental Tribune International GmbH. General
terms and conditions apply; legal venue is Leipzig, Germany.
All rights reserved. © 2022 Dental Tribune International GmbH.
Reproduction in any manner in any language, in whole or in part,
without the prior written permission of Dental Tribune International
GmbH is expressly prohibited.

[3] =>

[4] =>

First hybrid edition of EAO congress is critically evaluating
technological developments in dentistry
An interview with Prof. Irena Sailer, EAO congress chair
© EAO

Prof. Sailer, this is the first in-person
EAO congress since 2019. What can
participants look forward to, and
what are you personally looking forward to?
This EAO congress is a very special one, indeed, as it is the first time
since the pandemic started that the
EAO is holding an in-person congress.
Participants have the opportunity to
engage with colleagues and friends,
to learn from excellent speakers and to
benefit from everything that the EAO
has prepared for them in the exciting
international city of Geneva. EAO congresses have always felt like a family
reunion, a yearly meeting of the EAO
community. We hope to rekindle this
feeling again this year, as we have
missed it in the past years.

Prof. Irena Sailer.

n From 29 September to 1 October,
the annual scientific meeting of the
European Association for Osseointegration (EAO) is taking place as an
in-person event again, the congress
having been held in a virtual format
for the last two years, owing to
COVID-19. The meeting, being held at
Palexpo in Geneva in Switzerland, is
making its comeback in a hybrid format, presenting an online evening programme in the style of the EAO Digital
Days. In this interview, congress chair
Prof. Irena Sailer shares what participants can expect, explains the hybrid
format in more detail and introduces
a main focus of the congress programme: the critical examination of
investments in novel technologies and
their actual benefits for clinicians and
patients.

The congress is being held in a hybrid
format. Can you tell us a bit more
about this?
This year for the first time, we are
holding a hybrid congress—offering
two congresses for the price of one!
Each congress day has a virtual part in
the evening, similar to the EAO Digital
Days of the past two years. This digital
part is mostly for those who do not
want to or cannot travel to Geneva.
It features congress teasers and summaries of the respective day, such as
short summaries of the plenary sessions or live recorded parts of the discussions. Although it isn’t a replacement of the congress, the evening
programme is informative and entertaining.
The theme of the EAO congress is
“Uniting nations through innovations”.
Can you elaborate on what this means
exactly?
Well, many major global organisations, such as the World Health Organization and the Red Cross, are headquartered in Geneva. It is also known

for the United Nations Office, housed
at the Palais des Nations. This is what
inspired the theme of this special EAO
congress. The EAO is known for its international character, and it is our goal
to reunite nations in the discussion
about the influence of technologies
and innovations on our daily practice
and patient care.
A main topic of this year’s EAO congress is the evolving role of technology in implant dentistry. I saw in the
programme that some sessions will
be critically examining new technologies and investments in them. Can
you tell what is being covered during
the event?
The congress is focusing on the
timely and controversial topic of the
influence of technological developments on our practices and the treatment quality delivered to our patients.
It is, indeed, our aim to critically evaluate all the new developments that
are offered to clinicians today. All
these new tools that promise to improve quality of care while reducing
treatment costs for patients do sound
tempting, but we will ask whether all
of this can be achieved just by investing in technology and changing the
practice structure from a conventional
one to a digital one. Many dental professionals are asking what evidence
there is behind these rapidly appearing developments and whether the evidence is sufficient to abandon well-
established paths.
We will try to address these questions reasonably in all sessions, and
it is our aim to come to a conclusion
on the entire topic in the last plenary
session on Saturday. We will discuss
intensely which investments in technological developments are worth
making for daily clinical practice and
which are not. Thereby, the focus will

also be on the benefits for patients—
what are the patient-reported outcome
measures in the evaluation of new
technology?
What other topics concerning implantology and periodontics that
could be pioneering for dentistry will
be discussed?
The first plenary session will elucidate what virtual human technology
exists in areas outside of dentistry and
medicine. This session promises to be
truly exciting, as we dentists do not
know what computer graphics and
the entertainment industry can offer
today. The second plenary session will
be a live surgical session, in which
two highly experienced surgeons,
Drs Mario Roccuzzo and Istvan Urban,
will perform hard-tissue regeneration
supported by digital tools, and their
advantages and limitations will be
intensely discussed by a group of experts. The last plenary session will
summarise everything that has been
presented and will—more in a philosophical way—elaborate on the topic of
whether investment in new technology
really improves patients’ and clinicians’ lives.
In addition to these very interesting plenary sessions, the programme
will focus on innovations for treatment
planning and communication, for implant surgery and for implant pros
theses. The topics follow the sequence
of a treatment, and we hope that all
attendees will find something new to
learn, independent of their speciali
sation or practice structure.
In addition, interesting patient-
oriented topics will be covered, such
as a session on the unhappy patient.
It will focus on how communication
between clinicians and patients can
be improved and how expectations

can be better managed to avoid disappointment.
Since events started to return to
an in-person format, I have heard
from attendees that engagement
with other dental professionals has
gained greater priority than before
the pandemic. How is this congress
meeting this increased need for socialising and exchanging of experiences?
Our EAO office colleagues have
put great effort into establishing the
structure of the congress venue in a
way that is very inviting for socialising
and exchange. In addition, the evening
events, such as the members’ dinner
and other parties, are great occasions
to meet like-minded peers.
It goes without saying that we
are complying with all measures required in relation to COVID-19 throughout the EAO congress and related
events.
Would you like to add anything?
Because the congress is taking
place in Switzerland and because four
Swiss dental organisations (the Swiss
societies of implantology, of oral surgery, of periodontics and of reconstructive dentistry) are partners of
this year’s EAO congress, we are especially delighted to welcome our Swiss
peers! The organisations have organised a Swiss day, a highly interesting
and interactive congress programme
specifically dedicated to our Swiss
peers and association members which
is taking place on the first day of the
EAO congress. 7

Editorial note: The digital congress programme
will be available on the EAO online platform until
3 October. More information on the congress can
be found at congress.eao.org.

Innovations in bone regeneration
An interview with Dr Matteo Chiapasco, Italy
n On 30 September, notable expert
and prolific author in oral and maxillofacial surgery Dr Matteo Chiapasco
will be presenting at the EAO congress. Dr Chiapasco, who is an asso
ciate professor at the Department of
Biomedical, Surgical and Dental Sciences
at the University of Milan in Italy and
visiting professor at Loma Linda University in California in the US, founded
the Italian Academy of Osseointegration. He spoke with Dental Tribune International about his presentation.
Dr Chiapasco, how do you hope your
presentation “The new technologies
in bone regeneration, 3D bone grafts”
will impact EAO attendees?
I think that attendees will be extremely interested to learn about the
new developments in this fascinating
field, in particular those related to
CAD/CAM customised titanium meshes,

which may truly simplify bone regeneration of complex 3D defects and
shorten surgical time. Additionally,
they will learn more about the bone
regeneration techniques that are in
development to allow implant placement in compromised edentulous
sites, particularly in the case of complex 3D defects.
Are there any specific advances in
the field or changes in procedure
design that have caused you to take
notice? What developments over the
years have been most exciting, in
your opinion?
I consider the most relevant developments in this field to be firstly a multidisciplinary and integrated approach
to planning and treatment following the
principle of prosthetically guided regeneration, secondly the increasing importance of the reconstruction of peri-

implant soft tissue in atrophic
sites, and finally the simplification of procedures with the patient rather than the procedure
central to the clinical outcome.
As you have previously reviewed a number of techniques
for various procedures in implant dentistry, where would
you direct practitioners who
would like to learn more
about 3D bone grafts? What
would you suggest as a good
starting point—aside from
attending your presentation,
of course?
The best start would be
attaining a deeper knowledge
of surgical anatomy and the 5 Dr Matteo Chiapasco.
biological behaviour of the
various grafting materials, including
doing so can you follow with the techthe pros and cons of each. Only after
nical details of different techniques.

29 th EAO Annual Scientific Meeting · Geneva

In accordance with the theme
of the EAO section “Innovations
in regeneration”, what changes
or improvements in bone regeneration technology do you
foresee being developed or becoming more widely available
within the coming years?
I think that research must
be focused on two things: the
development of new material
to improve bone regeneration
without the use of autogenous
bone harvesting (provided
that the efficacy is the same
or better) and any procedure
which will reduce morbidity
and rehabilitation time. 7
Editorial note: As part of the innovations in
regeneration session, Dr Chiapasco will be holding his lecture, titled “New technologies in bone regeneration, 3D bone grafts” on Friday, 30 September at 11:15.

Geneva © Benny Marty/Shutterstock.com

interview

[5] =>

Restore the full beauty
of a smile in a day with
the All-on-4® treatment
concept

250,000

Over
patients*
successfully treated
Fixed full-arch prosthesis
on four implants

NEW!
Take edentulous treatment to
the next level with the synergy
of surfaces: TiUltraTM implants
and XealTM abutments

nobelbiocare.com/all-on-4
*Nobel Biocare (Data on file)
GMT 80959 © Nobel Biocare Services AG, 2022. All rights reserved. Nobel Biocare, the Nobel Biocare logotype and all other trademarks are, if nothing else
is stated or is evident from the context in a certain case, trademarks of Nobel Biocare. Please refer to nobelbiocare.com/trademarks for more information.
Product images are not necessarily to scale. All product images are for illustration purposes only and may not be an exact representation of the product.
Disclaimer: Some products may not be regulatory cleared/released for sale in all markets. Please contact the local Nobel Biocare sales office for current product
assortment and availability. For prescription use only. Caution: Federal (United States) law restricts this device to sale by or on the order of a licensed clinician,
medical professional or physician. See Instructions For Use for full prescribing information, including indications, contraindications, warnings and precautions.

Download
FREE e-book
How you can start with the
All-on-4® treatment concept

[6] =>

news

Is there still a scientific literature?
An editorial by Dr Mauro Labanca, Italy

Understanding the dramatic vicious
circle is quite simple: research about a
product or procedure, well-conducted
and with intellectual honesty on the
part of researchers, requires a great
deal of time and energy and, ultimately, a financial investment. When
there is a potential risk of the results
being unfavourable to what has been
studied, who then wants to spend
money on verifying the scientific validity of a protocol or a material that
will perhaps be modified owing to market requirements within a short time?
Moreover, it is very often enough to
comply with CE regulations, which
certify that a product has met EU
health, safety and environmental requirements, in order to market a new
product. This says nothing about its

Those were the days of in-depth
research, the days when the same
implant remained on the market for
years without significant changes and
the follow-up lasted for several years.
Then, as now, I used to try to
explain to those who attended my conferences how to read the documentation that accompanied new products
put on the market. I am now forced
to notice that the situation is taking a

worrying, and perhaps dramatic, turn.
This is certainly true for all sectors and
in all countries, but our profession,
dentistry, a profession where most are
freelancers, is paying the price in an
amplified manner for this increasingly
emerging phenomenon.

Dr Mauro Labanca.

efficacy or real intended use, and, therefore, supposedly therapeutic products
can be proposed to us without any
kind of scientific support or research
behind them. There can sometimes
be laughable documentation which
refers to general concepts and not to
the product in question.
Unfortunately, all this sometimes
occurs with the guilty silence of a
plethora of scientific societies that all
too often talk about the highest systems instead of making themselves, as
would be good and desirable, guarantors of the scientific nature of products
and protocols. Mala tempora currunt,
and it only remains for us to hope that
an individual capacity for criticism
will be able to guide young colleagues
towards conscious choices to prevent
experimentation on unsuspecting patients who honour us with their
trust—a trust which should never be
betrayed. 7
Editorial note: This article was published in the
Italian edition of implants—international magazine
of oral implantology, vol. 2, issue 2/2022.

Artificial intelligence and augmented reality in implant planning
An editorial by Dr Francesco Mangano, Italy
n Technology is now pervasive in
dentistry, and implantology is no exception. Intra-oral and face scanners,
CBCT and digital condylographs allow
us to acquire 3D images and videos of
our patients, useful not only for diagnosis but also for treatment planning.
The patient becomes virtual.

based software capable of returning
to the clinician, in a few minutes and
at very low cost, the entire set of
3D files of the patient (derived from
intra-oral, face and CBCT scanning).
These files, in STL format, are perfectly aligned and segmented, eliminating any possible error by the operator. Each tooth, for example, is the
result of the perfect fusion, segmentation and alignment of CBCT (root) and
intra-oral (crown) scans. The segmentation and alignment are automated,
being the result of a learning process
(machine learning) which represents
the basis of AI.
1

It is a real revolution that has
opened the door to changes in all fields
of dentistry: from the possibility, for
example, of planning a 3D orthodontic
set-up that is truly safe for the bone
to the planning of prosthetic complex
cases. In implantology, AI-assisted software such as Virtual Patient Creator
(Relu) allows us to enhance our diagnostic and planning skills.

Dr Francesco Mangano.

Until recently, however, this in
formation was difficult to segment and
assemble, and this limited the patient
virtualisation process. Obtaining the
virtual patient was difficult and costly,
needing time and effort, since segmentation and alignment were essentially
manual, and operator-dependent.
Today, thanks to artificial intelligence (AI), it is possible to use cloud-

In particular, the use of 3D files
in STL format processed by Virtual
Patient Creator (Figs. 1 & 2), combined
with modern virtual reality and augmented reality (AR) systems, creates
new possibilities. In fact, it is possible to upload all files derived from
AI-assisted software directly into apps
specifically designed for AR, such as
HoloDentist (FifthIngenium). Thanks
to these apps, wearing an AR device
such as HoloLens 2 (Microsoft), the
dentist can view the holographic
3D models of the patient and use them
to make a correct diagnosis and for
communication with the dental laboratory, colleagues or patients in order
to illustrate to them the selected treatment plan.

2
5

F ig. 1: Automatic segmentation from CBCT in Relu’s artificial intelligence-assisted, cloud-based software.
Fig. 2: Fusion and automatic alignment and superimposition of 3D files from the intra-oral scan over the CBCT data.

The use of AI and AR technologies
transforms the manner of not only
diagnosis and communication but also
of implant planning. On the basis of
the set of files segmented and aligned
via AI, the surgeon wearing AR glasses
such as HoloLens 2 or Magic Leap 2
(Magic Leap) can plan the positioning
of one or more implants in the correct
3D position, inclination and depth,

29 th EAO Annual Scientific Meeting · Geneva

sing holograms.* Basically, it is no
u
longer necessary to use software dedicated to guided implant surgery: the
surgeon drags and drops the desired
fixture from a 3D library provided by the HoloDentist app
and positions it within the
holographic model of the bone.
The surgeon can also enlarge
the holographic models to

such an extent that they
have the same dimensions
as the operator, and the
same applies for the hologram of the implant. Finally,
by navigating inside these
models, the surgeon can
tilt, rotate and otherwise
move the implant within
the bone hologram. This
process is also guided by
other masks and holograms, which can be on or
off during 3D planning, for
example that of the teeth
and soft tissue or that of
the prosthetic wax-up. This
is authentic 3D planning,
without the need for any
guided implant surgery
software or conventional
2D radiographic sections.
This allows planning in a
fast, intuitive and fun way,
drastically reducing costs.
The spatial position of the
implant thus designed is
saved and exported, together with the other files,
for the design of the sur
gical guide, in open-source
software. The next future
development will be the
import of this planning into
a dynamic implant navigation system. 7

Editorial note: As part of a session on innovations
in implant diagnostics and planning on Friday,
30 September, from 9:00 to 10:30, Dr Mangano will
be presenting a lecture, titled “Artificial intelligence
and augmented reality in implant
planning”, on this interesting topic.



*Scan QR code to watch a video on
3D implant planning with holograms
using HoloDentist and HoloLens 2.

n Many years ago, Prof. Pierluigi
Sapelli, having to organise a meeting on
evidence-based dentistry, “forced” me
to give a talk on the subject. This led
me to study in a frenzied way in order
to better understand what goes behind
a scientific publication and to familiarise myself with words that at the time
were almost unknown to those who
were not “super experts”. Thereafter,
I better understood the difference between personal opinions, published
here and there, and serious research,
multicentre studies, reviews, and
meta-analyses.

[7] =>

VISIT US AT
BOOTH D1

Zirconia
Implant System

Prosthetics perfected –
implants engineered.

axiomX3

®

B E Y O N D

F R O N T I E R S

[8] =>

interview

“Innovation in education and enablement is a continuous journey”
An interview with Dr Daniela Felipucci, head of global medical education at the Straumann Group
much implant therapy has changed
their lives. With this in mind, our goal
is to have an impact on ten million
smiles per year by 2030. To this end,
we offered thousands of educational
activities to dental professionals in
2021, and 35% of these were in countries where access to quality dental
treatment remains a challenge. This
access to treatment is further enabled
by our global expansion: our solutions
are now available in over 100 countries, and we serve customers in more
than 40 countries via our subsidiaries.
So, by training more and more dentists
and making our leading-edge solutions
available internationally, Straumann
contributes to better access to oral
care for patients and, in so doing, we
fully commit ourselves to this year’s
EAO theme “Uniting nations through
innovations”.

Dr Daniela Felipucci.

Dr Felipucci, where are we in the
evolution of oral care?
At the Straumann Group, stateof-the-art oral care is more than the
products and solutions provided—it is
a vital part of the patient’s overall
health and well-being. This is why we
are developing oral care by strongly
focusing on the patient’s needs. Together with our strategic partners, we
aim to improve access to oral care for
people all over the world, and we believe that fostering customer learning
and education is crucial here. We are
proud to report that approximately
3.7 million patients around the world
have been treated with our products—
restoring their dental function and
aesthetics and enhancing their quality
of life. Last year, we collected hundreds of patient testimonials. These
touching stories illustrate just how

education, run by selected experts, are
the places where science meets practice in a real-world clinical environment based on scientific evidence and
cutting-edge technology. We also run
our own training centres in China and
Latin America (the ILAPEO in Curitiba
in Brazil), and finally, since 1980, we
have been building a strong and fruitful
alliance with our scientific partner, the
International Team for Implantology.
How do you meet the very high and
diverse demands for education and
training?
Indeed, we definitely need to
analyse the specific needs of all our
different target groups and support
them with tailored educational offerings in their respective individual
career moments. To this end, we are
continuously working to perfect a
variety of effective educational formats and networking programmes
that focus on specific needs. Target
groups include beginners in implantology, general practitioners starting
with immediate protocols, customers
working in the field of periodontics,
specialists dealing with advanced
and complex indications, female
dentists with career development

“We are in constant exchange with about 500 clinical
and scientific experts globally, disseminating
the latest clinical and scientific evidence through
a variety of in-person or online formats.”

n All the Straumann Group’s brands
are driven by constant innovation and
product excellence, and consideration
of the patient’s needs, demands and
well-being is always the guiding
principle of the group’s daily efforts
in more than a hundred countries.
Tailored and technically advanced
training and educational offerings
have to meet the manifold needs of
dental professionals around the world.
They play a key role in achieving
cutting-edge oral care and, as a result,
in this year’s EAO theme “Uniting
nations through innovations”. In this
interview, Dr Daniela Felipucci, head
of global medical education at the
Straumann Group, talks about how
Straumann meets the needs for dental
education, the role of modern technologies in transporting knowledge, and
the company’s focus at this year’s EAO.

Who are your strategic partners
who help you achieve your long-term
educational goals?
Innovation in education and enablement is a continuous journey,
requiring flexible solutions. And the
Straumann Group cannot do it alone.
Therefore, we maintain close and longterm collaborations with leading clinics, research institutes, universities,
networks and communities in order
to foster research and innovation. We
are in constant exchange with about
500 clinical and scientific experts
globally, disseminating the latest clinical and scientific evidence through a
variety of in-person or online formats.
By providing the most advanced treatment procedures, our centres of dental

“Modern tools and platforms facilitate remote
training and remote live participation, whereas
assisted, augmented and virtual reality t echnology
can give dentists greater confidence.”
needs and the next generation of
graduates.
What is the role of new technologies
in maintaining relationships and
disseminating knowledge?
We have all experienced disruptions to our relationships as a result of
physical distancing owing to the pandemic, and technology has become
crucial in maintaining and further developing these relationships. In the
context of education, this new quality
of interaction leads to better engagement in the classroom and, ultimately,
to better learning outcomes. Modern
tools and platforms facilitate remote
training and remote live participation,
whereas assisted, augmented and virtual reality technology can give dentists greater confidence, as they are
able to continuously develop and
shape their skills. Another priority
was to make these modules affordable,
scalable and effective for dentists in
acquiring new knowledge. We have
started piloting a global mentorship
programme enhanced by assisted and
virtual reality. In addition, we are constantly nurturing our customers not
only with webinars, virtual events and
access to lectures on demand but also
with “snackable content” on our customer magazine youTooth.com, which
offers more than 500 easy-to-consume
articles, including clinical reports and
multimedia content.
All these efforts meant that edu
cation did not have to stop during the
restrictions of the pandemic. On the
contrary, it allowed professionals to
adapt to the challenging situation, to
evolve and to participate in education
without the need for travel, making
hands-on courses accessible for even
more participants, especially in remote locations. And as we are a
customer-centred company, now we
too are evolving and continuously
adapting to their new preferences for
learning and keeping up to date.
What is your focus during this year’s
EAO meeting?
As already stated, the patients
and their expectations and demands
are our main referral points because
we believe that a patient-centred approach is key to achieving an outstanding treatment. This will be reflected in our corporate forum on
digital immediacy, which is taking
place on 29 September from 16:30 to
18:30 in Room C. Particular attention
will be paid to digital planning and
proper implementation of treatment,
followed by the selection of the most
suitable components based on the
patient’s unique needs. 7

Participants of Straumann’s immediacy master course that was conducted in collaboration with its academic partner Beijing-Citident Implant-Dentistry Technology College in China.

29 th EAO Annual Scientific Meeting · Geneva

Editorial note: Straumann is showcasing its
products at Booth D1.

[9] =>

The Complete Workflow Solution

Learn More at KeystoneDental.com

[10] =>

interview

CleanImplant Foundation: Greater safety in implantology
and a stage for quality manufacturers
Interview with Dr Dirk Duddeck, managing director and head of research at the CleanImplant Foundation
Dr Duddeck, you have already conducted several quality assessment
studies. Have you seen a trend towards increasingly improved implant
manufacturing and thus greater
safety for patients?
In recent years, we have analysed
well over 300 implant systems from
many leading manufacturers using
a Thermo Fisher Scientific scanning
electron microscope and had the opportunity to evaluate qualitative manufacturing results over an extended
period. In the previous quality assessment study, approximately one-third of
implant samples have been found to be
contaminated with residue from the
manufacturing process or contaminants
attributable to the packaging process.

Dr Dirk U. Duddeck, managing director
and head of research at the CleanImplant
Foundation.

n The CleanImplant Foundation seeks
to promote global awareness of contaminated implant surfaces caused
by poor quality control during production and ill-conceived packaging
design. These deficiencies have been
noted in the foundation’s scientific
research framework and reported
in numerous publications in Europe
and abroad.1, 2 At the EAO congress,
Dr Dirk U. Duddeck, managing director and head of research at the
CleanImplant Foundation, is currently
collecting implant samples from manufacturers to complete the cohort of
the current 2021–2022 CleanImplant
Quality Assessment Study.

What contaminants have you found
on the implant surfaces?
The most frequently detected implant surface debris is a carbonaceous
compound identified as polysiloxane
(synthetic polymers and thermoplastic
materials), which is known to exhibit
toxic effects. In addition, residues of
erucamide (a fatty amide often used
as a lubricant additive in the plastics
processing industry) and dodecylbenzenesulfonic acid (an aggressive and
surface-active chemical that is classified as harmful to the health by the
US Environmental Protection Agency)
have been found on surfaces of sterile-packaged implants. These impurities can be avoided through quality
control of the production processes
and appropriate packaging techniques.
Do these factory-made impurities on
implant surfaces have any clinical
relevance?

A recent quality assessment study revealed that approximately one-third of sterile-packaged implants show factory-related pollutants.
This contamination, such as the organic, carbon-containing, contaminants shown, is clinically relevant, having been found to be linked
to bone loss and peri-implantitis (full-size, high-resolution SEM image mapping using back-scattered electron imaging, 500×). (All images:
© CleanImplant Foundation)

Yes! The clinical relevance has
been proved by many peer-reviewed
studies, which have concluded that
residues on implant surfaces present
a significant concern for treatment success. Organic, that is, carbonaceous, pollutants are associated with initial bone
loss and peri-implantitis.3 Foreign particles of 0.2–7.2 µm are considered to
be highly pro-inflammatory, and when
these particles detach from the surface
during implant insertion, they can create an expanding zone of soft-tissue degradation. The secretion of inflammatory
mediators such as tumour necrosis
factor-, interleukin-1, interleukin-6 and
prostaglandin E2 from the inflammation
zone can then stimulate the differentiation of osteoclast precursors into
mature osteoclasts.4,5 Contaminants have
been shown to disturb the patientspecific foreign-body equilibrium, a major cause of peri-implant bone loss, as
stated by Prof. Tomas Albrektsson.6

Dentists rely on the fact that implants which have received US Food
and Drug Administration (FDA) clearance or the CE mark have a residuefree surface—rightly so?
No, unfortunately not. All the implant systems that we have examined
had either a CE mark or FDA clearance.
As users of approved medical devices,
dentists should be able to trust that
all systems meet optimal quality standards. To establish an ideal industry
standard, the CleanImplant Foundation developed the “Trusted Quality”
seal in 2017. Only implant systems
with cross-batch cleanliness and high
clinical success rates—independently
analysed and peer-reviewed—can receive this quality seal. Our website is
a stage for quality manufacturers and
provides clinicians with study results
on the cleanliness of the implants
they use.
How has the non-profit project continued to develop? How effective is
the awareness campaign in reaching
dentists?
An increasing number of leading
implant manufacturers are applying
for the “Trusted Quality” seal. This
year, the CleanImplant Foundation
has expanded its activities to South
Korea and the US, opening an office,
CleanImplant North America, in
New York. Globally, the CleanImplant
initiative has seen its membership
increase dramatically, well beyond
our expectations. Currently, the
foundation has more than 120,000
Facebook subscribers and the number is increasing each day. They all
want more safety, for themselves and
their patients, because they understand that there is legitimate cause
for concern. 7

References
1. Duddeck DU, Albrektsson T, Wennerberg A, Larsson C, Beuer F. On the cleanliness of different oral
implant systems: a pilot study. J Clin Med. 2019
Aug 22;8(9):1280. doi: 10.3390/jcm8091280.
2. Duddeck DU, Albrektsson T, Wennerberg A, Larsson C, Mouhyi J, Beuer F. Quality assessment of
Dr Dirk U. Duddeck, managing director and head of research at the CleanImplant Foundation, in the laboratory.

29 th EAO Annual Scientific Meeting · Geneva

documentation. Int J Oral Maxillofac Implants. 2021
Sep–Oct;36(5):863–74.doi:10.11607jomi.8837.
3. Mouhyi J, Dohan Ehrenfest DM, Albrektsson T.
The peri-implantitis: implant surfaces, microstructure, and physicochemical aspects. Clin Implant
Dent Relat Res. 2012 Apr;14(2):170–83. doi: 10.1111/
j.1708-8208.2009.00244.x. Epub 2009 Oct 16.
4. Matthews JB, Besong AA, Green TR, Stone MH,
Wroblewski BM, Fisher J, Ingham E. Evaluation of
the response of primary human peripheral blood
mononuclear phagocytes to challenge with in vitro
generated clinically relevant UHMWPE particles
of known size and dose. J Biomed Mater Res.
2000 Nov;52(2):296–307. doi: 10.1002/10974636(200011)52:2<296::aid-jbm8>3.0.co;2-9.
5. Rader CP, Sterner T, Jakob F, Schütze N, Eulert J.
Cytokine response of human macrophage-like
cells after contact with polyethylene and pure
titanium particles. J Arthroplasty. 1999 Oct;14(7):
840–8. doi: 10.1016/s0883-5403(99)90035-9.
6. Trindade R, Albrektsson T, Tengvall P, Wennerberg A.
Foreign body reaction to biomaterials: on mechanisms for buildup and breakdown of osseointegration.

Editorial note: More information about the
CleanImplant Foundation can be found at
www.cleanimplant.com. EAO participants can
learn more at Booth F50.

tems: cleanliness, Surface topography, and clinical

five randomly chosen ceramic oral implant sys-

Clin Implant Dent Relat Res. 2016 Feb;18(1):192–203.
doi: 10.1111/cid.12274. Epub 2014 Sep 25.



Scan the QR code
for more information
about the CleanImplant
Foundation.

About the
CleanImplant Foundation
Dr Dirk Duddeck founded the
CleanImplant Foundation in 2016.
Today, more than 40 ambassadors,
high-profile experts from both the
scientific and clinical communities,
support the foundation’s global awareness campaign regarding the issue
of factory-contaminated implants. The
foundation regularly performs quality assessment studies in collaboration with renowned universities
using elaborate testing procedures
in specialised laboratories. After a
strict peer-review process, clean
implant systems are awarded the
“Trusted Quality” mark. More than
500 dentists and dental clinics
worldwide have been registered
as CleanImplant Certified Dentists
who use solely proven clean implant
systems for their patients.

[11] =>

Your solution for digital impressions
NeoScan™ 1000
COME VISIT
US AT
BOOTH #C55

Easy to use

The NeoScan 1000 is a fast and easy-to-use intraoral
scanner that provides the possibility for a flexible workflow
with open and compatible output.

Fast scanning

With a simplified cable connection, full-touch screen
support, and without the need for powder or pre-heating,
the NeoScan 1000 is what your practice needs and it
comes at the right price!

High precision
Attractive price

Neoss AG

•

The Circle 23

•

8058 Zurich-Airport

•

Switzerland

•

E distributors@neoss.com

[12] =>

interview

“Clinicians buy too many products and cannot necessarily
make use of all of them”
An interview with Dr Orcan Yüksel, Germany
aiming to make in this field with
I mplantStock?
This cloud-based software makes
it easier for dentists to carry out their
daily work using their own stock of
implants and various screws and
spare components. In the past, everything had to be selected from a box.
Today you can sort everything digitally with lot number and expiry date
and reserve it for use, and after use,
everything is assigned to a patient in
accordance with the law in the form
of an implant passport, if desired.
Patients should also have access to
information about components that
have been placed in the body without having to call the dentist. The
software ensures that patients are
always well informed.
5

Dr Orcan Yüksel.

n As an expert implantologist with
a busy clinic in Frankfurt am Main,
Germany, Dr Orcan Yüksel knows that
the ins and outs of placing dental implants, including logistical and organisational concerns, can be overlooked
amid busy clinical schedules. With
this in mind, he developed ImplantStock, a free-to-use app that enables
dental teams to manage their implant stock more effectively and eliminate the risk of valuable implant
stock expiring before it can be used.
Dr Yüksel spoke with Dental Tribune
International about the software and
the advancements that he hopes to
see at the EAO congress.
Dr Yüksel, you have developed a
cutting-edge product for dental implantology. What impact are you

all of them. Then they try to return
these products; however, suppliers
are not always willing to buy back
stock with shorter expiry dates, as it
may be difficult to sell such stock to
other dentists. This has always been
an uncomfortable subject. ImplantStock offers enormous help in selling
these products openly, ensuring their
quality and obtaining other products
that are needed for the next treatment. It may even be possible to obtain them at a reduced price, which
benefits the patient. In this way, a
topic that people are reluctant to ad-

dress has become an open topic and
practices can be relieved of recovering enormous capital that can be reinvested. It offers relief for industry and
practice, and ImplantStock does not
compete with manufacturers. Rather,
it is like a bank where you can see
your money in detail and a stock
exchange where you can sell some
shares and invest in others.
The EAO meeting is a world-leading
showcase of the field of implant
dentistry. What advancements do
you hope to see at the event?

The industry has been trying to
digitise everything for a long time,
and this has not always been easy
for clinicians, owing to the fact that
systems and devices have not ne
cessarily been able to communicate
effectively with each other. What is
needed are web-based technologies
that are secure but easy to use on a
laptop or tablet, without the complex
installations and updates that are
often painstaking and must be undertaken before a file can be processed
safely. We have a lot of catching up
to do in that regard. 7

Digital workflows are fast becoming the norm in implant dentistry.
In what areas do you think digitisation can further streamline dental
implantology?
Data that I always want to have
at hand, such as my own warehouse
of implant data, must also be accessible to me from anywhere. One cannot
rely on having access to a specific
place, such as practice rooms, or
patient cards. The freedom to do certain things that you have to do outside of the practice provides relief in
working routines.
In your experience of talking with
clinicians and distributors, what
are some of the key concerns today
when it comes to inventory and
implant storage?
Clinicians buy too many products
and cannot necessarily make use of

Since 1993, Dr Orcan Yüksel has been running his own practice in Frankfurt am Main, Germany, at which he also offers training courses in implantology.

Streamline your practice and surgical planning
with free-to-use ImplantStock
Manage your implant stock, and have it on hand when it is most needed
n All too often, dental clinics store implants that they do not currently need,
and other valuable stock expires or is
not at hand when it is most required.
A new, free web-based solution aims
to help clinics take charge of their
implant stock management so that
clinicians and their teams can focus on
providing the best possible treatment
to their patients.

The software provides dentists
with a dynamic overview, allowing
them to keep track easily of expiry

dates and thereby eliminate the loss
of valuable stock. Dental teams can
order directly from their preferred

ImplantStock enables clinics and
laboratories to manage their implant
stock like never before—from anywhere, at any time. With the software, practices can register their
stock—including the implant length
and sizes. As well as taking the stress
out of surgical planning and streamlining the ordering of new stock,
ImplantStock offers a number of advantages for dental professionals, such
as optimising workflows and reducing
costs.

29 th EAO Annual Scientific Meeting · Geneva

manufacturer or distributor, and they
can even offer their stock to other dental practices when an implant system

is changed or when the wrong implants or components were ordered—
a situation with which all too many
clinicians will be familiar.
The online tool also streamlines
communication within the team and
makes it easier for practice managers
to manage stock effectively and prevent hassles occurring in front of the
patient.
ImplantStock is a win for dental
teams, laboratories and manufacturers,
and the feedback from clinicians is
clear: ImplantStock reduces costs,
saves time and allows them to focus on
surgery instead of searching for the
necessary tools.
For more information about this
solution from ImplantStock, EAO visitors can stop by Booth A4, or visit
implantstock.com. 7

[13] =>

news

Store it better with ConsyBox
Convenient, safe, intelligent storage for dental implants
For distributors, ConsyBox also
brings a list of benefits. It helps them
to stay in control of their consigned
products and to initiate just-in-time
invoicing for customers and the automatic shipment of new products
from manufacturers. The system
helps to increase
the productivity of sales

 ConsyBox is a new product for
the storage of dental implant stock,
and it provides benefits for dental
teams and distributors. Those who
have adopted the ConsyBox praise
its automatisation of orders and
consignments and the reduction of
paperwork enabled by the digitised
storage system.
ConsyBox is a steel box for the
digital age. It allows clinicians to
store dental implants and components in a single storage unit that
is specifically designed to meet the
stringent storage criteria for bio-

staff by enabling
customers to order
dental implant stock as they need it,
and additional savings are gained
when distributors can finally say
goodbye to inventory checks, the
damage or loss of goods and unacceptable storage conditions at customer premises.

materials set by EU medical
device regulations. Above all, it
helps dental teams to manage their
cashflow efficiently and extend the
digitisation of their workflows to include implant storage, ordering and
stock management.

ConsyBox’s digital inventory
management is based on expiration
dates and includes an early warning
system to ensure that no implants
are overlooked. Choose the product,
reserve it for treatment, and you will
be restocked automatically. Get it
done digitally with ConsyBox!

The system digitises documentation, is compatible with any recordkeeping and accounting software
and automates restocking, thereby
making paperwork a thing of the
past. It also eliminates unnecessary
costs by facilitating the return of
unused implant stock to distributors
and bills only when a product is
placed in the patient.

Visit Booth A4 or the company’s website for more information:
www.consybox.com.. 
AD

Guided implantology

Precise. Efficient. Versatile

Guided endodontics

Guided bone surgery
Expand your surgical expertise
Less trauma for your patients
Save precious time
Try Navident’s precision guidance for yourself.
Call +32.475.75.52.26 or email info@claronav.com
Visit us at Booth G10 at EAO Congress

[14] =>

news

Osstem-Hiossen Meeting 2022 to take place in Autumn
The symposium returns to Europe; more than 700 participants expected
ian cuisine will offer great networking
opportunities in a relaxed atmosphere.
Cultural performances will entertain
the guests.

 AIC Europe, which was founded in
2001 by Osstem Implant, has confirmed that the Osstem-Hiossen Meeting in Europe 2022 will be held as
planned in October in Rome. In addition to a series of lectures to be presented on various topics related to
dental implant procedures, the twoday symposium will feature a live surgery, a round-table discussion and an
oral competition.
The last European symposium in
Prague in the Czech Republic gathered
dentists from more than 30 countries
in Europe, the Middle East, Africa and
the US. Owing to the SARS-CoV-2
pandemic, the symposium has had to
be suspended for the past two years.
This year, the organisers are looking
forward to finally welcoming participants to a new edition of the symposium, which will be held on 28 and
29 October at the Auditorium del
Massimo congress centre in the city
of Rome.
More than 20 renowned experts,
including Prof. Bilal al-Nawas from
Germany, Dr Darko Božić from Croatia,
Dr Silvio Meloni and Dr Francesco
Mintrone from Italy as well as Waldo
Zarco Nosti from Spain, will be speak-

The whole symposium will be
livestreamed through Osstem’s own
global broadcasting system, DenAll TV,
and other related channels.

Help for Ukrainian refugees
Recently, AIC Europe and Andrea
Bocelli Foundation (ABF) have launched
the #TogetherHasNoLimits campaign
to fundraise throughout the year and
in particular during the 2022 OsstemHiossen Meeting in Europe to help
children and families that have fled
the conflict in Ukraine.



The fundraiser will run until
31 December and has a target of €50,000.
Donations can be made through the
symposium website.

The Osstem-Hiossen Meeting in Europe 2022 will be held in Rome.

ing about the latest in implant dentistry. Special guest Dr David Chong
from the US will be opening the symposium.
The last session on the first day
will be dedicated to a round-table discussion, in which Dr Marco Tallarico
from Italy, Dr Hyun-Jun Jung from

Korea and Dr Chong will explain different approaches to the maxillary
reconstruction of terminal dentition.
A highlight of the symposium will
be the live surgery that will be performed on the second day by Dr Jung
and Dr Roberto Scrascia from Italy.
Moreover, dentists and dental students

will have the opportunity to present
their cases in an oral competition or
in the poster zone. Abstracts were
submitted in three categories—
digital dentistry, prosthetics
and oral surgery.
On Friday night, a gala
dinner featuring the finest Ital-

For more information, please visit
www.osstem-europe-meeting.com or
booth #B47 at the EAO congress in Geneva. 



Scan the code to register.

Taking a closer look at soft-tissue adaptation to the abutment
An editorial by Dr Luigi Canullo, Italy
 Recent literature has shown that
the interaction between soft tissue
and a foreign body such as an abutment is mediated by the characteristics of both the material from which
the abutment is made and the surrounding tissue, that is, the biotype.1
However, when analysing this in detail, it can be observed that different
variables are involved in this interaction.
In a clinical context, soft-tissue
adaptation seems to depend on its
histological characteristics but, above
all, on the individual healing and
inflammatory pattern (epigenetics).
However, it has been shown that the
prosthetic workflow influences the
healing pattern, as do the surface
properties of the abutment, which can
be classified into macro, micro and
nano. An abutment with convergent

macro-geometry has been associated
with improved maintenance of periimplant bone levels and greater aesthetics, whereas a moderately rough
surface microtopography seems to
represent the optimum for adhesion
between the connective tissue and the
abutment.2
Looking even more closely, it can
be deduced that the electrical and
surface energy characteristics are a
key factor for adhesion between the
connective tissue and the abutment:
a decontaminated and bio-activated
abutment can produce far stronger tissue adhesion and, consequently, minimises peri-implant bone resorption.3
Another key parameter is the microbiological contamination of the oral
environment, which greatly influences
the interaction between the abutment
and the connective tissue.4

Considering these findings, it is
apparent that soft-tissue adaptation
to the abutment is a complex clinical
phenomenon resulting from the
interaction of different variables.
This may suggest that the abutment
connection should be considered the
last phase of the surgical protocol, which
implies then the need for complete
sterility of the prosthetic workflow. 
Editorial note: As part of a session on innovations
in implant design, components and materials on
Friday, 30 September, from 11:15 to 12:30, Dr Canullo
will be giving a lecture titled “Different concepts
of modifying the transmucosal component”.

References
1. Canullo L, Annunziata M, Pesce P, Tommasato G,
Nastri L, Guida L. Influence of abutment material and



Dr Luigi Canullo maintains a private practice in Rome in Italy with a focus on surgery and
implant-supported prosthetic rehabilitation.

modifications on peri-implant soft-tissue attachment:
A systematic review and meta-analysis of histological

426-436. doi: 10.1016/j.prosdent.2020.01.025. Epub

animal studies. J Prosthet Dent. 2021 Mar;125(3):

2020 Mar 18. PMID: 32197823.

2. Canullo L, Menini M, Santori G, Rakic M, Sculean A,
Pesce P. Titanium abutment surface modifications
and peri-implant tissue behavior: a systematic review and meta-analysis. Clin Oral Investig. 2020
Mar;24(3):1113-1124. doi: 10.1007/s00784-02003210-x. Epub 2020 Jan 18. PMID: 31955269.
3. Corvino E, Pesce P, Mura R, Marcano E, Canullo L.
Influence of Modified Titanium Abutment Surface
on Peri-implant Soft Tissue Behavior: A Systematic
Review of In Vitro Studies. Int J Oral Maxillofac
Implants. 2020 May/Jun;35(3):503-519. doi:
10.11607/jomi.8110. PMID: 32406646.
4. Canullo L, Masucci L, Quaranta G, Patini R,
Caponio VCA, Pesce P, Ravidà A, Penarrocha-Oltra D,
Penarrocha-Diago M. Culturomic and quantitative
real-time-polymerase chain reaction analyses for
early contamination of abutments with different surfaces: A randomized clinical trial. Clin Implant Dent
Relat Res. 2021 Aug;23(4):568-578. doi: 10.1111/
cid.13028. Epub 2021 Jul 1. PMID: 34196453.



According to Dr Luigi Canullo, the abutment connection should be considered the last step of the surgical protocol.

29 th EAO Annual Scientific Meeting · Geneva

[15] =>

news

What is driving the European dental implant markets?
An analysis by Simon Trinh, research analyst at iData Research



Dental implant market growth in Europe. (Source: © iData Research)

 Unsurprisingly, the COVID-19 pandemic crippled the entire dentistry
industry in 2020 and 2021, when elective medical surgeries such as dental
implant and bone grafting procedures
were postponed. Some countries,
namely Switzerland, Belgium and the
Netherlands, recovered more quickly
than others, and others were heavily
affected by extended shutdowns, particularly those that rely on patients
from abroad, such as Italy. However,
this impact on the market is relatively
straightforward and predictable, devastating as it may be, and recovery
will be a linear process. What is far
more intricate to uncover are the factors that are driving the industry on
a broader scale, looking years ahead
instead of months.
It would be foolish to begin a discussion of market drivers for dental
implants without addressing the
most obvious factor: an ever-growing
ageing population that naturally has
a higher incidence of missing teeth

and the need for aesthetic dentistry
procedures. Once again, however,
this is an obvious avenue of growth.
A far more compelling patient-driven
trend to discuss is cost and its implications.
It is not surprising that implant
procedures are expensive by nature;
however, it comes as more of a shock
that there is almost no insurance
coverage or reimbursement for such
procedures. It is true that in some
countries, such as Sweden, Germany
and the Netherlands, governments do
provide some form of reimbursement
for dental implant procedures. However, coverage is usually limited and
partial reimbursement is only so useful when the cost of a typical procedure is already so high. Furthermore,
most private health and dental insurance policies do not cover dental
implants. This is a severe hinderance
for procedure growth, particularly in
the younger demographic who cannot easily afford a procedure costing



Overview of the surgical guide market by manufacturer type. (Source: © iData Research)

thousands of euros compared with
people in their 50s or 60s.

Value segment companies
flooding the European
implant market
The use of cheaper implants is
driving market growth, not in terms
of sheer market value but in terms of
procedure numbers. Nowhere is this
more evident than in the Italian market, where there is a perfect storm of
cost sensitivity and massive demand
for aesthetic dentistry. Previously,
patients had no alternative to expensive, premium implants, but dentists
are now able to offer significantly discounted products at a fraction of the
cost. Implants were once dominated
by European products, but companies
from South Korea, Israel and Argentina, to name a few, have emerged in
great numbers in the market. Opening
the market up to patients who could
previously not afford such treatments
has contributed to a substantial increase in potential procedure volume.

“It comes as more of a shock that there is almost no
insurance coverage or reimbursement for [implants].”
Increasing number
of general practitioners
placing implants

surgical guides and their use during
procedures.

Many would assume that the materials are only a fraction of the cost
of the procedure and that the majority
of the expense comes from treatment
by a specialised dental implant professional, particularly in light of the limited availability of such practitioners.
That was the case until recent years.
Much more evident in the US but
still a growing trend in Europe is the
increased number of general practitioners who are able to perform dental implant procedures. Many postgraduate education programmes and
training courses have gained popularity among general practitioners
seeking to broaden their skills and increase the services they can offer.
This has had two major benefits:
a sizeable increase in the number of
professionals who are able to offer
dental implant services and the potential for longer-term decreased costs to
patients as a result of this growing
supply.

Additionally, an increasing number of dental schools are incorporating
the latest technological advancements
into their curricula, exposing prospective
dentists to a wider array of available
tools and reducing the time and effort
needed to learn to use these. Also, of
course, while an investment in computer technology such as treatment
planning software greatly benefits
dental professionals in terms of both
efficiency and scope of services they
can offer, it ultimately improves the
quality of service delivered to the patients. The use of computer aids allows
for maximum customisation for each
individual patient case and higher levels
of accuracy during procedures. 

It is all about
digital technology
Lastly, and certainly not a trend
on the forefront of everyone’s mind,
is the slow but steady development
and integration of digital dentistry.
Over the course of the last two decades, digital dentistry has revolutionised the industry. While dental
professionals are not known for their
technological literacy or desire to be
on the front lines of digital innovation
within their practices, sentiment has
dramatically changed in recent years,
and this trend is an inevitability
over time. This is particularly true for
new dentists entering the market who
are increasingly aware of the digital
technologies available to them, such as
treatment planning software, CAD/CAM,
and software supporting the design of

About iData Research
For over 15 years, iData Research
has been a strong advocate for
data-driven decision-making within
the global medical device, dental
and pharmaceutical industries. By
providing custom research and
consulting solutions, iData empowers its clients to trust the source
of data and make important strategic decisions with confidence.
More information can be found at
https://idataresearch.com.

About the author
Simon Trinh is a research analyst
at iData Research. He develops
and composes syndicated research
projects regarding the medical
device industry.

29 th EAO Annual Scientific Meeting · Geneva

[16] =>

interview

“At Neoss, we have the luxury of being able to be more forward-oriented”
An interview with Dr Robert Gottlander, CEO at Neoss

From left: Neoss CEO Dr Robert Gottlander and Dental Tribune International CEO Torsten Oemus at the Neoss booth at EuroPerio10.

parts of the dental community, including clinicians and manufacturers.
The dental community works better if
it’s integrated and when we all work
together.
Choosing Gothenburg as the location for the meeting was probably no
coincidence, considering that Neoss
has its origins in the city and Gothenburg is very closely connected with



From left: Dental Tribune International CEO Torsten Oemus, Neoss CEO Robert Gottlander and
Dental Tribune International editor Franziska Beier in conversation.

The meeting as such exceeded our
expectations, and we are very happy
with the outcome.
You called the meeting “Integrate
2022”. Does that imply a further integration process in the coming years?
The basic plan—which has not
been officially confirmed yet—is to
have five to seven small meetings in
different countries next year and to
have another Integrate meeting in 2024.
That’s the plan, but we will have to see
whether it works out.
I really like the name “Integrate”
because for a lot of dentists daily work
is about integration. I think that what
we have learned during the pandemic
is that we really have to integrate all

Per-Ingvar Brånemark, who was central
to osseointegration research.
Neoss is based on the tradition of
implantology from Gothenburg. We try
to stick to the basics, to follow Brånemark’s principle, which was to always
think about the patient. Therefore, as
a company, we think about what we
need to do for the clinician in order to
get the best outcome for patients.
The office in Gothenburg is very close
to the University of Gothenburg’s dental
school, and we are in the same building as
the Department of Biomaterials. I think
that Neoss is more focused on science than
other implant companies are—although,
I don’t know if we are an implant company.
I don’t think so. I don’t want us to be.

What do you want Neoss to be, if not
an implant company?
I think we would like to be a company that helps dentists treat patients
in the best possible way, in an ease-ofuse way but with predictable results.
Today, implants are very different
from what they used to be 40 years
ago, and I think that implants in the
coming 20 years will be different too.
The tools being used—such as scanners
and software—are also being used in
many other treatments. Three decades
ago, an implant crown used to be
made completely differently from a
crown for a tooth. Today, there is no
difference. In this way, implant dentistry has come closer to other fields
of dentistry. This shift is evident in all
of the traditional implant companies
because they are different from what
they were 20 or 30 years ago. At
Neoss, we want to offer technology
that is easy to use and to stick to our
intelligent simplicity. Simplicity has
always been important, but I think it
is becoming even more important.
In my opinion, this development
has to do with today’s dental education system. When I went to dental
school, we learned a lot about very
few things. Today, there are so many
different dental specialties; however,
the time students spend in dental
schools has not been expanded. Therefore, today’s students learn, I don’t
want to say little, but less about a lot.
As a result, when they leave dental
school, they need to find a way to get
more education. In addition, students
and clinicians have changed their
view of life. When I graduated, the
main goal was to become a specialist
or to have one’s own private practice.
Today, a lot of dental students want to
be employed, and that means that the
requirements for manufacturers are
changing. We have to develop products and handle education in a different way. At Neoss, we aim to back up
our products with an immense effort
in training and education because
I believe manufacturers have to take
responsibility for showing dental

29 th EAO Annual Scientific Meeting · Geneva

professionals how our products are
supposed to be used.
So, with regard to your question
about what I think Neoss should be—
these are the topics we try to think
about. We are not a large company,
and I think that the biggest advantage
of that is that we do not have to adhere
to a strict traditional structure and
this flexibility gives us the possibility
of doing things that will make a difference in the future. Legacy implant
companies need to concentrate on
how to manage their business. At
Neoss, we have the luxury of being
able to be more forward-oriented.
Many implant companies are branching out into areas that are not part of
their core business—such as aligners
and intra-oral scanners. Neoss just
launched the NeoScan 1000. What
was the rationale for this product?

simple use built on science. When developing the scanner, we did not focus
on multiple software features but on
it being fast, precise and really easy
to work with. It’s very lightweight—
it only weighs 198 g—so basically the
weight of a smartphone. The mirror is
a bit lower, so the captured image
is larger than usual. If something is
missed while scanning, the user can
go back and the scanner will pick it
up quickly, which really reduces the
scanning time. It has one button for
the upper jaw and another one for the
lower jaw, so actually the user can’t do
anything wrong.
So, it’s idiot-proof?
Yes, that’s my point! [laughs] This
scanner is for dentists who want a
simple scanner that takes a precise
picture at a very competitive price.
I think that at the moment it’s the
scanner with the best price–performance ratio on the market. Most other
scanners in the same price range don’t
have a colour mode or don’t work at
the same speed. The speed of our product is the same as that of high-end
scanners. We just don’t have all the
different modules for the software.
However, it’s truly open. The dental
professional can incorporate the
scanned data into other design and
scanning software. It’s for dental professionals who want to focus on their
clinical work. We presented data at
Integrate 2022 which shows that the
precision of our scanner is at least as
good as the leading brands on the
market today.
Would you like to add anything else?
We have another product that we
wanted to highlight: NeoGen, which is
a non-resorbable PTFE titanium membrane. These membranes are actually
not easy to work with, but if used
correctly can achieve vertical bone
growth in a way that is amazing. We
have had this product for five to six
years, and it has been well researched.
© Dental Tribune International



Dr Gottlander, this year, Neoss is
celebrating 20 years of intelligent
simplicity. You invited the dental
community to join your company from
9 to 11 June in Gothenburg in Sweden
for Integrate 2022. Can you tell us a
bit more about the event?
Neoss is in a period of change.
We are building on strong product
lines and strong research and increased
communication. We had over 600 participants, and from what I heard from
external and internal participants,
they really enjoyed it. The goal for us
was to integrate, educate and celebrate.
Our basic feeling is that education
“only” is no longer sufficient, because
people are used to getting new information on the Internet, especially
since the pandemic. What is lacking is
exchange. Our event offered short lectures and the opportunity to engage
with speakers and other participants
by asking questions and having discussions. In addition, we offered evening events, like themed dinners.
We thought that this mixture would
attract participants, and it really did.

 At EuroPerio10, Dental Tribune
International met up with Dr Robert
Gottlander, who took over the position of
CEO and president of Neoss at the end
of 2020. In this interview, he shared his
vision for the future of his company
and how dentistry is changing and with
it the demands for manufacturers and
explained what makes Neoss’s new
high-precision intra-oral scanner unique.



The new NeoScan 1000 scanner from Neoss is easy to use, very precise and fast.

We have had the ScanPeg for five
years. It is the smartest digital workflow
product currently on the market, offering the combination of a scanning abutment and a healing abutment. I thought:
this is really smart, but we cannot really
sell it unless we also offer a scanner.

I joined Neoss because of its
great implant product line, including
its easy use and predictable, wellresearched outcomes—and because of
its novel products, such as the ScanPeg
and PTFE membrane. Very few companies have such an offering. 

What makes your scanner unique?
We stuck to the easy-to-use approach. I really believe in intelligent,

Editorial note: Neoss is showcasing its products
at Booth C55.

[17] =>

Plan surgeries easily
Reserve from your stock digitally.
Order missing implants prior
to operation online.

Follow up expiring
implants
Keeps track of the expiry dates, so that you
can use them before it’s too late or offer for
sale or exchange.

Control and monitor your
implant stock from
anywhere at any time
Enjoy your holidays, weekends, dinners, time with
family. No more sleepless nights because of OP
planning.

[18] =>

news

Economic slowdown and inflation dog dental sales
Results for the second financial quarter of 2022. By Jeremy Booth, Dental Tribune International

The second financial quarter of
this year was not without its ups and
downs. Leading dental laser manufacturer BIOLASE reported a 70% increase in laser sales in the US and
growing momentum in the uptake of
dental lasers among dental specialists.
For fellow US company, Dentsply
Sirona, it was the lack of a quarterly
report that was most significant. The
Nasdaq-listed North Carolina company is now two quarterly reports in
arrears and has been non-compliant
with Nasdaq listing rules since 18 May.
Dentsply Sirona warned in August
that it would not file its second quarter
Form 10-Q, owing to “an internal investigation regarding certain financial
reporting matters”. It was also reviewing previous accounting practices and
evaluating whether its 2021 financial
results need adjustments. The beleaguered company said in a business update that it expects to report second
quarter net earnings of US$1.005 billion (€1.006 billion) and that supply
chain difficulties and a drop in sales in
China had affected its performance.
Henry Schein CEO Stanley Bergman told analysts that SARS-CoV-2 infection rates had risen in June in some
regions, leading to a decline in dental
patient traffic. He said that price inflation for brand manufacturer dental
merchandise sold by Henry Schein
had reached approximately 3% during
the quarter, but that the impact of inflation on dental equipment sales had
been relatively insignificant. In July,
annual inflation rates in the eurozone,
the US and the UK reached 8.9%, 8.5%
and 10.1%, respectively.
Henry Schein’s global dental sales in
the second quarter totalled US$1.9 billion,
representing a drop of 3.1%. The multinational’s dental sales were driven by
strong equipment sales owing to continued investment by dentists in their
dental clinics, Bergman said.

Clear aligner manufacturers
cite unprecedented headwinds
SmileDirectClub (SDC) sounded
the alarm for the direct-to-consumer
(D2C) space in late 2020, and Align
Technology has now confirmed it for
the dentist-led segment: clear aligner
sales are not immune to macroeconomic pressures.
Align’s run of six quarters of sequential growth ended in the first
quarter of this year, and its total revenues for the second quarter reached
US$969.6 million, a 0.4% sequential
decline and a 4.1% year-over-year dip.
Invisalign case shipments of 598,990
were flat compared with the first
quarter and down 10% year over year.

 The ongoing SARS-CoV-2 pandemic
and the war in Ukraine are affecting
dental markets, and inflation and recession are two words that are currently weighing heavily on the minds
of dentists and their patients. Results
for the second financial quarter of this
year show that some dental companies, particularly those who mainly
sell clear aligners, are feeling the pinch
of a looming economic slowdown.

Yu and Aghdaei pointed to supply
chain disruptions, accelerating inflation
and a severe COVID-19-related lockdown in China as having significantly
affected Envista’s performance. Yu said
that inflation was having a major impact on the industry and leading to a
drop in investment in capital equipment and to inventory reductions.
Speaking about effects resulting
from the war in Ukraine, Aghdaei said:
“We think the European economy
and risk associated with the energy
supply is going to weigh heavily [on]
this industry. Right now, as expected,
Europeans are on vacation, and the
forecast for what we will see after September is just not as clear as what we
have seen in the past. We are waiting
for the dust to settle to see where this
ends up.”



The SARS-CoV-2 pandemic and the war in Ukraine have resulted in rising inflation and shrinking consumer confidence, both of which significantly
affected the performance of dental companies during the second quarter of this year.

Clear aligner revenues of US$798.4 million were down 5.1%, and those from
imaging systems and CAD/CAM services
rose slightly to reach US$171.2 million.

Similar to other major dental
companies, SDC is banking on cost
savings and new innovations to help
it through.

“The decisions we make this year will have
lasting strategic implications for the future
of our industry and the competitive landscape.”
—Joe Hogan, CEO, Align Technology
CEO Joe Hogan said in a conference call that the quarter had been
tougher than expected. He cited ongoing effects resulting from the SARSCoV-2 pandemic—in particular, broad
lockdowns in Chinese cities—but also
rising inflation and a worsening consumer outlook as significant headwinds faced during the period. Hogan
told analysts: “As we continue to navigate macroeconomic uncertainty and
weaker consumer confidence and impacts related to COVID-19 variance,
we cannot lose sight of the strong fundamentals of our business and the
enormous market opportunity for digital orthodontics and restorative dentistry. The decisions we make this year
will have lasting strategic implications
for the future of our industry and the
competitive landscape.”
Indeed, D2C giant SDC finished
the second quarter by revealing more
details about its move into the premium, dentist-led clear aligner segment.
As SDC’s core demographic continues
to struggle financially and steer its
spending away from products, the
company is broadening its focus to
target the higher-income households
that may typically opt for Invisalign
or other premium clear aligner treatments. SDC’s total revenue for the period was US$126 million—down 17.0%
sequentially and 27.8% year over year.
It shipped 62,705 unique sets of
clear aligners in the quarter, which
was 17.8% fewer than during the first
quarter.

Straumann performs well
despite uncertainties
Lockdowns in China had a heavy
impact on the Straumann Group’s performance in the Asia Pacific region,
but CEO Guillaume Daniellot said that
macroeconomic challenges had yet to
affect the group. “In the first half of
the year, we didn’t see a heavy impact
by the ongoing economic challenges
yet. Despite the current macroeconomic uncertainties, we feel confident
to confirm our full-year guidance,”
Daniellot commented in an earnings
media release.
In fact, Straumann performed
notably well. Second quarter revenue
of CHF589.4 million (€613.9 million)
represented a year-over-year increase
of 14.3% and brought total earnings
for the first half of a financial year to
more than CHF1 billion for the first
time.
On a year-over-year basis, Straumann’s sales increased by 12.9% in the
Europe, Middle East and Africa region,
by 13.0% in North America, by 8.5%
in the Asia Pacific region and by 49.5%
in Latin America.
Inflation had some impact on
patient volumes in the US towards
the end of the second quarter, but
patient flow in Europe remained
steady, the company said. However,
it did cite inflation and COVID-19
lockdowns as increasing uncertainties.

29 th EAO Annual Scientific Meeting · Geneva

Envista warns on energy
supply in Europe
Sales at Envista increased moderately during the period, despite challenges that affected the company and
the dentists and dental support organisations that it serves. Having recently
met with more than 100 Envista customers during a road trip across the
US, CEO Amir Aghdaei shared some of
the insights that he gained during the
tour with investors. He said: “While
there is no doubt that talk of inflation
and potential for an economic slowdown is weighing heavily on clinicians’ minds as they look out over the
next six to 12 months, it is also clear
that quality patient traffic remains
robust, and dental professionals remain confident in the long-term prospects of the industry and their businesses.”

Yu said that core sales growth in
Western Europe during the period
was 11.0%, significantly ahead of
North America, where an increase of
0.5% was recorded. Around 14–15% of
Envista’s business is located in Russia
and China. Envista’s core sales growth
in Russia declined by mid-single digits
during the quarter, and core sales
growth in China was down 0.3%.
Apart from Russia and China, emerging markets continued to rebound
from pandemic lows and showed
sales growth of approximately 20%
year over year.

Dentistry well placed to
weather the storm?
Speaking about the looming economic slowdown, Bergman hinted that
dentists do have cause for optimism.
“The market Henry Schein serves has
weathered past slowdowns quite well.
During the challenging economic
times, consumers continue to need
services from office-based healthcare
practitioners,” he said.

Aghdaei explained that the performance of dental clinics had been
limited during the period mainly as
a result of supply chain constraints
and difficulties finding staff, but that
strong patient volumes had been reported by specialists.

And whereas it will be a challenge
to operate in the current financial environment as the pandemic continues,
dental companies may be able to use
some of the strategies that they developed after the outbreak of SARS-CoV-2
in order to shore up their businesses.

Envista’s sales of US$645.8 million for the quarter represented an increase of 1.3%, and core sales growth
for the period was 4.0%. A significant
contributor was the Ormco clear
aligner product Spark, sales of which
increased by 27.8% sequentially. Chief
Financial Officer Howard Yu pointed
out that it had taken Envista three
years to achieve the milestone of
100,000 Spark case starts and that
50,000 patients began treatment with
the clear aligner system in the first
half of this year.

When asked how Align would
respond to a scenario in which consumer confidence continued to sink
and in which inflation and unemployment continued to climb, Hogan said
that the company would adjust its
business to lower demand, as it had
done at the start of the pandemic. “If it
gets worse, and it could get worse […]
[Chief Financial Officer John Morici]
and I come from businesses where
we’ve been through these cycles.
We know how to operate in a down
cycle,” Hogan commented. 

“We think the European economy and risk
associated with the energy supply is going
to weigh heavily [on] this industry.”
—Amir Aghdaei, CEO, Envista

[19] =>

PROTECT

YOUR

PATIENTS
THE ‘PERIO PLUS
REGENERATE’ REVOLUTION:
+ Inspiring fresh taste sensation
+ Proven more effective
than pure CHX*
+ Regeneration and protection of
oral mucosa
+ Additional protection against
infections* and the causes of bad
breath
*Studies on www.perioplus.com/studies

THE
T
A
S
U
T
VISI
STAND
4
NO. A2

AT
W
O
N
E
UT MOR

FIND O
OM
C
.
X
O
R
P
CURA

[20] =>

Help your patients say yes!
An editorial by Dr Kübel Özkut, Turkey
Engagement with patients

Dental fears

Effective listening is the key to
finding out what motivates patients,
what they think about their smiles and
what it is that they would like to improve.3 It is not about selling dentistry;
it is about getting to know our patients
and even partnering with them so that
we can create a win–win situation.
Asking questions, particularly openended ones, can help encourage patients
to communicate their oral health-related
desires; for example:

Unfortunately, dental fears are
c ommon and often keep patients from
getting the treatment they need. When
patients look at before and after photographs of similar cases we have completed, it can help to ease their fear and
earn their trust, making them much
more likely to accept the treatment. It is
imperative that the patient understands
exactly what the treatment involves
and how we plan to keep him or her
comfortable. This includes enquiring
about his or her concerns, covering the
possible consequences of not receiving
treatment and focusing on the advantages of the proposed treatment.

 On a scale of 1–10 (1 being poor
and 10 being excellent), what level
of oral health would you like to
achieve?
 Have you ever encountered problems with chewing, or have you
had mouth or tooth pain?
 How important is your smile to you
and to your confidence when interacting with people, both personally
and professionally?
 If you had a magic wand, what
would you like to change about
your smile, if anything?
 Diet affects oral health. Could you
please tell me about your diet?

Dr Kübel Özkut.

n The last two years have certainly
been challenging times, and many of
us have been understandably worried
about what it all means for the future
of our businesses. The additional weakness of systems that were already
struggling prior to the COVID-19 pandemic have become even more magnified and that certainly is not helping us
regain our patient numbers.
Since the beginning of the pandemic, we as dental professionals have
put a great deal of effort into making
our patients feel safe and protected so
that they can properly maintain their
oral health by receiving any necessary
treatment. However, knowing how to
execute excellent dental treatment
and having the opportunity to provide
treatment to our patients are two
different things. Getting patients to
schedule the treatment we recommend can be difficult, but it is vital to
our practices’ success. The acceptance
rate should be greater than 80% for
existing patients and between 50%
and 75% for new patients.1
It is imperative to take the time to
explain to each patient why he or she
needs the particular treatment, and
we must do our best to answer all of his
or her questions. Despite receiving all
the necessary information concerning
the proposed treatment, many patients
leave the office without scheduling an
appointment for the treatment—some
never to be heard from again. While
this can be quite a frustrating situation, it can also be an opportunity to
make improvements to our systems
to raise case acceptance rates.

If we want patients to accept treatment, we need to fully understand
what it is they really desire. When
we have the same priorities as our
patients, our practices’ retention and
case acceptance rates will go up.
Patients will feel more in control of
the process and appreciate that we
have really understood their needs
and values—thereby fostering loyalty
and trust.2 They will not feel pressured
into accepting treatment they do not
really want. Instead, they will gladly
accept treatment that will help them
meet their oral health goals.

Lack of time
Lack of time is a common reason
for treatment delay. Like most people,
our patients are often very busy and
may forget to call to schedule treatment
once they leave the practice, sometimes
despite knowing the importance of
their dental health and the importance
or urgency of the proposed treatment.
To overcome this, we can train our treatment coordinator to follow up with the
patient two days or a week after the
initial case presentation is made. That

“It is not about selling dentistry; it is about getting
to know our patients and even partnering with
them so that we can create a win-win situation.”
Research has found that nearly 68%
of those who avoided or delayed visits
to the dentist gave the expense as the
primary reason.4 While multiple reasons
were given, the cost of going to the dentist was mentioned more than twice as
often as anything else.4 Most patients do
not put money away specifically for dental care and have no idea how they are
going to pay for treatment.5 In my experience, if they are not in pain, patients
often convince themselves that they do
not need treatment, which inevitably
leads to more complicated problems and
additional costs down the road.
We should take the time to educate patients in detail before talking
about costs, making sure that they
understand the value of the care we
provide. If it is because they do not really see the value of the treatment, we
should educate them about their condition and the possible consequences
of not receiving the treatment. Once
patients understand why they need
treatment, price becomes less of a barrier. In our clinic policies, we should

We dentists may be excellent clinicians and superior at treatment planning, but presenting treatment plans
to the patient is something better delegated to a well-trained staff member.
For example, having a treatment coordinator who goes over every detail
with the patient in a comfortable, quiet
environment, giving him or her the
opportunity to ask questions without
feeling rushed, can be very effective.
Conversations supported with digital
tools to demonstrate treatment options
visually also help patients understand
the benefits of the suggested treatment
and help them feel more connected to
the practice, which of course makes
them more comfortable about scheduling treatment. If we want to improve
case acceptance in our practice, we
should ask for the patient’s final de
cision after presentation of the suggested treatment and explore any barriers to acceptance with the patient.

offer different financing options for
our patients, showing them that we
are also ready to support them.

way, the conversation is still fresh in
the patient’s mind. We can use these
calls as an opportunity to educate patients even further and address any
lingering concerns. Patients will appreciate the extra effort and gain a better
understanding of the recommended
treatment and why it is necessary.

Efficient recall and retention
programme
Retaining a current patient is far
easier and more cost-effective than attracting a new patient, so investing time
and effort in an efficient patient recall
and retention strategy is essential. In an
effective recall and retention programme,
patients should visit twice a year.
The recall and retention strategy
should involve making patients aware
of the practice’s services and the
value of the ongoing care that the
team provides. This includes the amazing advancements in dental materials
and digital technologies and the treatment options available. It is important
to emphasise the improved patient
experience and faster results that can
be achieved with these tools.
In summary, an efficient, structured case presentation policy ensures
that patients say yes to our treatment
plans. It also addresses one of the core
values of dentistry, which is commitment to oral health as a component
of the general health of our patients.
When we gain and retain patients who
value our practice, we will have the
opportunity to practise with less stress
and more joy in our clinics. 7
References
1. P hilhower J. Measuring case acceptance. Dent Econ.
2015 Sep;105(9):62.
2. Dunning DG, Lange BM, editors. Dental practice
transition: A practical guide to management. 2nd ed.
Ames: Wiley; 2016. 528 p.
3. J ameson C. Great communication = great production.
2nd ed. Tulsa: PennWell; 2002. 319 p.
4. A
rmfield J. The avoidance and delaying of dental
visits in Australia. Aust Dent J. 2012 Jun;57(2):243–7.
doi: 10.1111/j.1834-7819.2012.01697.x.
5. Jameson C. Collect what you produce. 2nd ed. Tulsa:

Effective listening and allaying dental fears are just two parts of helping your patient say yes to continued treatment.

29 th EAO Annual Scientific Meeting · Geneva

PennWell; 2005. 283 p.

news

[21] =>

[22] =>

industry

STRAUMANN PROVIDES LEADING INNOVATIONS FOR THE DENTAL PRACTICE
 The Straumann Group is a leading
innovator in the field of dentistry
and has many strong brands under
one roof. Constant innovation and
perfection remain the basis of the
company’s success, both in implantology and orthodontics. Straumann
aims to enhance the customer and
patient experience in order to improve oral care and, by bringing together products, digital technology
and artificial intelligence, creates
smart solutions that offer seamless
workflows and help reduce time to
teeth. At this year’s EAO, Straumann
would like to dive into all these
exciting topics with the congress
participants.

Artificial intelligence
The Straumann Group is actively working in the field of artificial intelligence-driven predictive
diagnostics, which offers great

for orthodontics, implantology and
CAD/CAM restoration, as well as 3D
printing for temporary or definitive
restorations chairside.

Dynamic surgical navigation:
Partnership with mininavident
Dynamic surgical navigation
is the next step in the digitalisation of dental surgery.
With an investment in the
Swiss company mininavident, the Straumann Group

aims to support each of them with
tailored educational offerings for
their respective individual career
moments. To achieve this, Straumann
is continuously working to perfect a
variety of state-of-the-art educational
formats and networking programmes.
These are in implantology, immediate

The patient
is always
centre stage
Straumann
strongly believes
in a patient-centred
approach as a key
to achieving state-ofthe-art dental care.
Treatment solutions
not only have to be reliable, predictable and personalised, but they also must
reduce the overall treatment time.
This is the reason why immediate
protocols and digital workflows
have such a strong impact on modern implant dentistry, as they offer
a variety of benefits for patients and
help clinicians treat specific indications, especially in the aesthetic
zone.

will further develop its technology
with the aim of providing a bestin-class platform for navigated
surgery.
potential and provides advanced opportunities. These include the accelerated detection of complications
either pre- or post-implant therapy or
during orthodontic treatment.

Seamless workflows
and integrated software
The product offering includes
integrated software and scanners

Secure implant registry
A new secure implant registry
with a web-based user interface
empowers clinicians to collect and
analyse their clinical data more efficiently, tracking the treatment outcomes of their patients.

Tailored educational offerings
Every customer has individual
educational needs, and Straumann

protocols,
periodontics,
career development, practice building, graduate programmes and much
more.

Straumann Corporate Forum: Digital immediacy in
the daily practice
Straumann is holding a corporate forum at the EAO congress on
29 September between 16:30 and
18:30 in Room C. Immediate protocols
and digital workflows have revolu-

tionised implant dentistry, as they
offer a variety of benefits for patients
and help clinicians treat specific indications, especially in the aesthetic
zone. During this corporate forum,
world-renowned speakers will discuss successful immediate treatment
concepts for different reconstruction
modalities, from single-tooth
restoration to full-arch rehabilitation. Particular attention
will be paid to appropriate
treatment planning and selection of the most
suitable components
based on patients’
unique clinical needs.
The forum will be
chaired by Dr Eirik
Salvesen (Norway).
Speakers will include Dr Maja
Chmielewska (Poland), who will
hold a lecture on
traumatic injuries
in the aesthetic
zone, Dr Abid
Faqir (UK), who
will present on
“The first mandibular molar—everyday life in my clinic”, and Dr Panagiotis
Papaspyridakos (US), who will discuss whether fully digital immediate
full-arch reconstruction is already a
reality. 
Straumann, Switzerland
www.straumann.com
Booth D1

KS SYSTEM: KEY SOLUTION FOR STRONG DENTAL IMPLANTS
Owing to the KS abutment holding system, the system facilitates
abutment seating. According to Osstem,
the KS implant and superstructure
stay connected even before tightening
the screw, and the abutment does not
fall out even when the implant is held
upside down and shaken. Additionally,
the KS is the only implant system on
the market that offers single-handed
use, in this way improving access
and implementation for the dentist.
Osstem also noted that the system



Finally, the surface of the KS system is coated with barium, a superhydrophilic coating that boosts
osseointegration by increasing blood
adhesion. The substance is 100% bioabsorbable and provides excellent
healing efficacy, thus improving
the success rate of dental implants
in patients who show bone loss.
According to Osstem, barium attracts blood to the titanium surface
and allows for the rapid formation
of woven bone, thus improving the
initial stability of
implants and increasing the implant’s
ability to form bone
and remodel itself. 

The KS implant system offers single-handed use.

 Osstem Europe, the European
headquarters of Osstem Implant, one
of the world’s major dental implant
manufacturers, has introduced a
next-generation implant system, the
Key Solution (KS) implant in Europe.
The system, which has a unique internal design, enhances the strength
of dental implants and provides a
convenient platform for surgery or
prosthesis loading.
According to Osstem, the KS implant system provides durable stability for patients and easy access and

manipulation for dentists. The solution has an internal hexagonal connection and a 15 degree Morse taper,
which provides larger angular compensation. The hexagonal connection also ensures high structural stability against external loads.
Additionally, the company noted
that, compared with existing products, the KS system can better endure
the forces and stress dispersion
around dental implants. Owing to the
15 degree Morse taper angle, the KS
implant system increases the coronal

wall thickness of the
connection of implants
and can enhance their
strength and maximise

fracture resistance. The
Scan the QR code for
system also has a sinmore information.
gle platform that facilitates prosthetic plan-  According to Osstem Implant, the KS implant system has a solid structure, offers a
convenient single platform allowing easy prosthetic loading and can reduce chair time.
ning and improves
clinical workflow, thus
can prevent the seated superstrucreducing chair time. Moreover, owing to
Osstem Implant,
ture from being pushed up by the
abutment compatibility, the KS system
South Korea
reduces prosthesis connection error
gingiva or the misconnection of
www.osstem.com
and also reduces inventory burden,
the superstructure during flapless
Booth B47
surgery.
thus enabling efficient stock control.

29 th EAO Annual Scientific Meeting · Geneva

[23] =>

industry

NEXT-GENERATION SOFT-TISSUE AUGMENTATION MATERIAL
 When choosing a biomaterial,
there is a strong demand in clinical
practice for predictable outcomes.
For over 20 years, LifeCell, a leading
global medical technology company,
has developed innovative products
for use in a wide range of applications. BioHorizons Camlog has expanded its soft-tissue portfolio with
NovoMatrix, an innovative softtissue augmentation material prepared using LifeCell technology.

NovoMatrix comes pre-hydrated
and ready to use and offers a true
alternative to autogenous soft-tissue
grafts and current products on the
market. The NovoMatrix indications
include guided tissue regeneration
procedures in recession defects for
root coverage, localised gingival augmentation to increase keratinised
tissue around implants and natural
teeth, and alveolar ridge reconstruction for prosthetic treatment. 

NovoMatrix is an acellular extracellular dermal matrix consisting of
tissue-engineered porcine material.
It is a breakthrough in xenogeneic
processing, providing a structurally

BioHorizons Camlog,
Switzerland
www.biohorizonscamlog.com
Booth C11

intact, undamaged scaffold that
supports cell and microvascular in-

growth. The proprietary tissue processing allows for rapid revascu-

larisation, cell repopulation and
minimal inflammation.

NEXUS IOS: A COMPLETELY DIGITAL SOLUTION FOR FULL-ARCH REHABILITATION

How does Nexus iOS work?

To understand how Nexus iOS
works, it is necessary to understand
why conventional scan bodies and
intra-oral scanning have not rendered
consistent results when performing
full-arch scans. Intra-oral scanning
works by 3D mapping a patient’s
tissue and dentition via photography
and software algorithms that stitch
image data into a 3D model.



Nexus iOS scan gauges and an intra-oral scanner.

 Nexus iOS is a completely digital
full-arch solution for end-to-end prosthetic restoration, from the first scan
to the definitive patient prosthesis.
Nexus iOS requires only an intra-oral
scanner and a scan gauge kit.
The search for an accurate
method of full-arch implant capture
has been a continual point of debate
among implant dentistry professionals, particularly in relation to intra-

oral scanning.1 New technologies
adapted to the dentistry field, like
photogrammetry, have sought to
solve these challenges. However,
they often carry significant investment and offer just one part of the
puzzle. Nexus iOS utilises existing
intra-oral scanning technology with
a new scan gauge tool which shares
similarities with conventional scan
bodies at first glance yet is significantly more sophisticated.

The function of translating 2D
images into 3D models is where
intra-oral scanning has the potential
to introduce inaccuracies.2 This is,
in part, due to the mouth being an
ever-changing environment with
soft-tissue movement, saliva and
other unstable features that make
the stitching of scanner data difficult, as there are limited consistent
landmarks for scanner algorithms to
use as points of reference. This is
made significantly worse when patients have no dentition at all, only
implants, often spread evenly across
the arch, leaving large gaps of soft
tissue to scan. Conventional scan
bodies offer some consistencies.
However, they do not cover the
span of the arch, so artificial soft-



Nexus scan gauge kit.

ware stitching still encounters
tissue-only scanning surfaces. One of
the ways Nexus iOS overcomes this
issue is by using scan gauges that
bridge the gaps between implant
sites, offering intra-oral scanners
consistent landmarks when scanning
across the arch, limiting tissue stitching and thereby increasing the likelihood of true scan data.

What is the outcome
of using Nexus iOS?
Using an intra-oral scanner and
a Nexus scan gauge kit, a series of
scans and patient headshots are performed to attain digital references of
the implant positions, patient’s bite
and aesthetic considerations. This
data is uploaded to the Nexus cloud
platform, and a titanium bar-retained
prosthesis is ordered. Design considerations, including tooth shade, gingiva colouring and distal cantilever,
are all taken into account during
ordering.



3D tooth set-up for approval.

A digital design is created, and
the clinician receives the 3D tooth
set-up for approval. Using the online
portal, all design changes are made

until the clinician is happy with the
set-up. A 3D-printed try-in is available
prior to manufacture of the definitive appliance, ensuring accurate
and aesthetic outcomes for the patient.
Nexus iOS was developed by
industry-leading implant prosthetic
manufacturer Osteon Medical from
Melbourne in Australia. 
References
1. Flügge T, van der Meer WJ, Gonzalez BG, Vach K,
Wismeijer D, Wang P. The accuracy of different
dental impression techniques for implantsupported dental prostheses: a systematic review
and meta-analysis. Clin Oral Implants Res. 2018
Oct;29 Suppl 16:374–92. doi: 10.1111/clr.13273.
2. Mangano FG, Hauschild U, Veronesi G, Imburgia M,
Mangano C, Admakin O. Trueness and precision
of 5 intraoral scanners in the impressions of
single and multiple implants: a comparative in
vitro study. BMC Oral Health. 2019 Jun 6;
19(1):101. doi: 10.1186/s12903-019-0792-7.

Keystone
Dental Group, US
www.keystonedental.com
Booth F47

29 th EAO Annual Scientific Meeting · Geneva

[24] =>

industry

NOBEL BIOCARE TO HOLD MASTERCLASS IN AESTHETIC IMPLANT AND RESTORATIVE DENTISTRY
ative materials resulted in a lot of
complications, and we had to adapt
our clinical workflow and the mate
rials.
I think there has also been a clear
shift thanks to digital technologies.
Porcelain-fused-to-metal restorations,
for instance, are seldom used any
more. Nowadays, we can offer hybrid
solutions, such as a titanium intermediate abutment used with a digitally
designed and milled zirconia restoration. The accuracy and the precision of these new technologies are
extremely high. During the three days
of the masterclass, we will also focus
on the choice of materials and the respective biological and technical complications that have to be considered.
5

Participants who complete the course will earn 21 continuing medical education credits.

n One of the most comprehensive
courses in advanced implant treatment, featuring live surgeries and
hands-on sessions, will take place at
the University of Zurich in Switzerland from 10 to 12 November, supported by Nobel Biocare. The company spoke with Prof. Daniel Thoma,
co-organiser of the course, about the
surgeries that will be performed and
about how participants can benefit
from learning in a small group over
the course of three days.
Prof. Thoma, the live surgeries will
focus on soft- and hard-tissue management in the aesthetic zone. Why
are these procedures essential for
an aesthetic outcome?
Soft-tissue augmentation procedures are the basis for providing the

best aesthetic outcome and essential
to maintaining peri-implant health.
We provide participants with the
whole workflow. Traditionally, attendees watch some workflows in a 2-minute video; however, in our masterclass, they will follow surgical procedures for around an hour.
How do you assess the success of
aesthetic outcomes?
That’s an extremely difficult
question. In research, there are many
indices and measurements. The most
well known is the pink aesthetic
score. Recently however, there has
been scientific evidence of some discrepancy between professionally assessed outcomes and patient-reported
outcomes. So, how do you tell if a
treatment has been successful? In my

Prof. Daniel Thoma.

opinion, a treatment has been successful if the patient is happy with
the result. Achieving the highest pink
aesthetic score does not necessarily
mean success, because often patients
cannot tell the difference. Today, we
have changed the way we provide
patients with dental care based on
studies that consider patient-reported
outcome measures.
Treatment planning should be simple and predictable. To what extent
do digital technologies help fulfil
this goal?
I would guess that digital tech
nologies cover 80%–90% of the entire
treatment. Mock-ups, for example,
are made fully digital today in most
cases. Digital technologies really help
us in simplifying the treatment be-

cause they take away some basic decisions. For instance, implant placement with guided surgery takes away
a lot of stress because the surgeon already knows exactly how much bone
he or she has to work with and what
difficulties to expect before the surgery is performed.
Tell us about the choice of reconstructive materials. What criteria
should be considered?
We try to take an evidence-based
approach, as we have seen some development in the past couple of years.
I remember that about ten
years ago we were able to provide the patient with a lot of
different materials. Thanks to
science, we observed that the
use of some of these restor-

What are the goals of this year’s
masterclass?
The course will show the entire
implant therapy, including initial
examination to definitive restoration
and long-term outcomes. I think participants will really like the smallgroup experience. Our entire team
will be with them for the whole three
days, so it will be easier to answer
questions related not only to the surgical interventions and lectures but
also, more generally, to their clinical
work. 7
Nobel Biocare,
Switzerland
www.nobelbiocare.com
Booth C29



Scan the QR code to register today.

THIS NOVEL MOUTHWASH PROTECTS YOUR PATIENTS IN THREE WAYS
n Curaprox’s Perio plus regenerate belongs to a new
generation of chlorhexidinebased mouthwashes that
employ a unique blend of
additives. It supports tissue regeneration, but also
prevents bacterial infection, making it ideal for use
after surgery and for relieving treatment-related
dry mouth. Here are three
ways Perio plus regenerate
protects your patients’
health.

the teeth healthy and helps
prevent caries. Oral bacteria
such as Streptococcus mutans
cannot metabolise xylitol,
resulting in the bacteria
dying off.

Using Perio plus
regenerate
The patient should rinse
with 10 ml of Perio plus regenerate undiluted for 60 seconds, morning and night, for
up to one month.
Patients must be warned
that Perio plus regenerate
is for oral application only
and must not be swallowed.
It should also be kept out of
reach of children

Stronger effect
but fewer
side effects
Two key components
of Perio plus regenerate
are chlorhexidine and
Citrox. Chlorhexidine digluconate (0.09%) has been
the gold standard of oral antiseptics
for decades. Citrox is a novel organic
antibacterial made from bioflavonoids and is sourced from bitter oranges. It is effective against bacteria,
viruses and fungi.
Studies have shown that the
combination of Citrox and chlor

hexidine is more effective than using
chlorhexidine alone. Citrox in Perio
plus regenerate is combined with
polylysine amino acids to create
the Citrox/P formula, which offers
a long-lasting antibacterial effect.
Thanks to this unique blend of in
gredients, it is possible to reduce the
amount of chlorhexidine used and
consequently its side effects.

An extra layer of protection
Hyaluronic acid is an important
part of the Perio plus regenerate
formula. Thanks to its water-binding
properties, it humidifies the oral
mucosa, supporting regrowth of
cells. It also protects the regenerating mucosa by creating a protective
biopolymer film over it. This acts
against dry mouth, reduces the risk

29 th EAO Annual Scientific Meeting · Geneva

of infection by viruses and bacteria,
and supports the formation of new
mucosal cells.

For a sample of Perio
plus regenerate and the
other Perio plus formulations, scan
the QR code below.7

Caries prevention
Xylitol not only contributes to Perio plus regenerate’s pleasant taste without
spiking blood sugar and
insulin, but also helps keep

Curaden,
Switzerland
www.curaden.com
Booth A24

[25] =>

www.consybox.com

A smart box for the convenience
of distributors and clinics

No paperwork,
all digital!
The ConsyBox is developed for
management of the implant stock
in the clinics. It is a fast and precise
tool for ordering goods and digital
communication between distributors and clinics!
It is fully in line with the latest
regulations of the European
Medical Devices Regulation for
storage and traceability.

Choose the
product

Reserve it
for treatment

The ConsyBox
is smart

You will be
re-stocked
automatically

Fill the stock

You are ready
again for the
next treatment

Full automatisation of your consignment and
instant control of the product taken from the
box.

[26] =>

industry

NEOSS GROUP IS SHOWCASING NEOSCAN 1000—NEW EASY-TO-USE INTRA-ORAL SCANNER
n At Neoss Integrate 2022 in June in
Gothenburg in Sweden, Neoss Group
launched its new easy-to-use intraoral scanner, the NeoScan 1000,
which quickly became a favourite
among everyone testing it. Now, the
intra-oral scanner is available for
all dental professionals to purchase
from the Neoss online store and from
local sales professionals or customer
services. Dental professionals can
also test the novel scanner at the
EAO congress at the Neoss booth
(#C55).
“Finally, we can share the
NeoScan 1000 with the full dental
community. The positive feedback
from our users has been exceptional.
While I knew it was good, the feed-

said Dr Robert Gottlander, CEO and
president of Neoss Group.
This easy-to-use, accurate, compact and lightweight intra-oral scanner enables a flexible workflow with
open files, making the output very
easy to share among the dental team.
With an easy USB cable connection
and full touch screen support, the
NeoScan 1000 will excite dental professionals alike—and it comes at a
very affordable price!

back has confirmed it is even better.
This intra-oral scanner will make it
possible for more dental profession-

als to afford to do digital impressions, saving many patients from the
trauma of a traditional impression,”

“The NeoScan 1000 is a superfast, lightweight and easy-to-use
scanner. I had the pleasure of being
part of the early testing and have
used the scanner for several digital
impression indications at my clinic

with excellent results. Digital dentistry is in need of more cost-efficient
solutions so that clinicians can use it
to its full potential. The NeoScan 1000
has the potential to do just this,”
commented Dr Marcus Dagnelid,
board-certified prosthodontist.
Neoss is offering hands-on courses
led by Dr Dagnelid on the NeoScan 1000
at the EAO congress. Dental professionals are invited to join the
workshops on Friday, 30 September,
either from 09:00 to 11:30 or from
14:00 to 16:30 at the Neoss booth. 7
Neoss, Sweden
www.neoss.com/neoscan1000
Booth C55

GUIDED BIOFILM THERAPY: A MODERN, UNMATCHED AND COMPELLING CLINICAL PROTOCOL FOR PROPHYLAXIS
n By Dr Neha Dixit, Switzerland:
Petersilka et al. said: “If a new form
of therapy is to be considered worth
integrating into standard periodontal
therapy, it either has to be superior in
therapy outcome or has to show other
relevant advantageous aspects such
as patient preference or operator convenience or economy of time or other
resources.”1
Focusing on oral hygiene, which
forms the gateway to maintaining good
oral and systemic health, is the need
of the moment. The Guided Biofilm
Therapy (GBT) protocol represents and
follows the recommendations of the
European Federation of Periodontology, stating that to have a successful
treatment outcome, professional prophylaxis must be complemented by
equally good oral hygiene at home.
GBT is part of a comprehensive
preventive concept that aims not only
to preserve patients’ oral health but
also to improve patient compliance
and subsequent recall attendance.
It is a modular, systematic, predictable
and logical solution for oral biofilm
management in prophylaxis using
state-of-the-art technologies such as
AIRFLOW MAX, PERIOFLOW with
AIRFLOW PLUS powder and PIEZON.

exist today. The protocol can be
adapted to every clinical situation in
the dental practice, from prevention of
early caries and periodontal disease to
maintenance and, in many cases, treatment of periodontitis and mucositis.
This protocol can be applied to all patients in supportive periodontal therapy and forms the basis of treatment
for patients in initial, non-surgical periodontal therapy.
GBT involves eight steps that can
be modified depending on the clinical
situation. The aim of this protocol is to
be minimally invasive, preserve hard
and soft tissue, and meet patient expectations. Like any innovation that
comes into being in this day and age,
when recommendations on correct
usage are followed, this protocol has
been proved to be highly efficacious,
safe and comfortable, not only for the
clinician but also for the patient.
Following the patient thorough
periodontal screening and recording
of the results and using a disclosing
agent to visualise biofilm not only
guides the patient towards pursuing
better oral hygiene but also aids the
clinician in achieving more efficient,
predictable supragingival biofilm re-

tains particles of approximately 14 µm,
causes the patient no discomfort and
preserves the natural integrity of teeth,
dental implants, restorations, orthodontic appliances and prostheses.

Dr Neha Dixit, global lead of clinical affairs and professional education at the Swiss Dental
Academy and EMS scientific and clinical affairs manager. (Image: © Neha Dixit)

moval. Disclosing the biofilm also
enables the clinician to build trust and
confidence with the patient, since it assures quality clinical outcomes. Additionally, it improves patient motivation
and helps re-educate patients on efficacious tooth cleaning, especially in
areas in the mouth that are often
neglected or are difficult to access.
Using the AIRFLOW technology
with the Guided Laminar AIRFLOW
MAX in probing depths up to 4 mm

EMS is presenting its latest innovation at the EAO congress: the new
PIEZON PI MAX instrument, developed
as part of the company’s mission of
continuous improvement of patient
and clinician comfort. It is a unique
instrument for non-surgical periodontal
treatments around implants and restorations. Made of a high-tech PEEK material, it allows easy access to calculus
up to 3 mm subgingivally. Using the
PIEZON PI MAX instrument, which is
50% more flexible than the previous
generation, calculus removal is minimally invasive and painless for patients.

and the PERIOFLOW nozzle in deep
pockets up to 9 mm with erythritolbased PLUS powder removes all supragingival and subgingival biofilm in the
most minimally invasive and highly
comfortable way. This helps to visualise
all the supragingival calculus easily,
avoiding over-instrumentation.
The erythritol-based PLUS powder
is a unique, versatile solution that
removes all supragingival and subgingival biofilm in only one step. It con-

If any hard calculus remains, use
is made of piezoceramic ultrasonic
technology by employing the PIEZON
NO PAIN PS instrument. This highquality, Swiss-made instrument, designed like a periodontal probe, is
not only efficient supragingivally but
also removes all stubborn calculus up
to 10 mm subgingivally. A clean oral
cavity without stains, biofilm or calculus
supports clinicians in better visualising
and checking for any caries, white spot
lesions and furcations in a much more
predictable way.
Enrolling patients in a regular recall system is highly dependent on
their personal experience during treatment. In a survey of more than 76,000
patients, more than 92% preferred GBT
and more than 98% experienced neither pain nor unpleasant sensations
(the current count is 126,657 participants, in whom the results were confirmed).2
To conclude, Petersilka et al.’s
assertion on the need for a superior
therapy protocol that offers a number
of advantages, including patient preference and operator convenience in
relation to time management, is fulfilled through GBT, which has been
integrated by GBT-certified practices
globally. 7
References
1. Petersilka G, Koch R, Vomhof A, Joda T, Harks I,
Arweiler N, Ehmke B. Retrospective analysis of the
long-term effect of subgingival air polishing in
supportive periodontal therapy. J Clin Periodontol.
2021 Feb;48(2):263–71. doi: 10.1111/jcpe.13392.
Epub 2020 Nov 9.
2. Koch JH. Die “Guided Biofilm Therapy” ist der
absolute Favorit bei den Patienten: Weltweite Umfrage
zu bevorzugter Prophylaxe-Methode. ZMK. 2022

The GBT protocol, which is supported by scientific evidence, was developed in 2016 by EMS, together with
academics, researchers and clinicians
across the globe, to overcome all the
challenges related to prophylaxis that

Apr;38(4):183–5.

29 th EAO Annual Scientific Meeting · Geneva

EMS, Switzerland
www.ems-dental.com
Booth C47

[27] =>

CLARONAV INTRODUCES NAVIDENT 4
quickly and confidently and in
reliably detecting important anatomical structures.
 In endodontics, clinicians can
locate root canals and other fine
anatomical structures with precision and efficiency.
 In bone surgery, the high-precision navigation of the Piezotome
(ACTEON) enables accurate assessment and predictable outcomes.

 ClaroNav is introducing a solution for dental providers who are
looking for ways to elevate and differentiate their practice from mainstream dental providers. Navident 4
provides breakthrough surgical
navigation in combination with advanced function and form. It promises to revolutionise dental treatments, including more efficient
single-tooth implant replacements
and rehabilitation workflows for

fully edentulous patients. The product is now available at a special
pre-order rate and is being showcased at the EAO congress at the
ClaroNav booth (#G10).
Navident 4 can be used in different fields of dentistry; for example:
 In implantology, it helps dental
professionals in conducting highprecision implant treatments

The new Navident system
is equipped with next-generation
3× resolution camera technology,
provides an ergonomic design and
a reimagined touch screen interface,
and is intended to enable smooth
workflow integration for clinicians at
every stage of their career. It comes
in cart-based or new wall or ceiling
mounting configurations for ultimate
versatility. 

ClaroNav,
Canada
www.claronav.com
Booth G10

© Alexander Demyanenko/
Shutterstock.com

industry

USEFUL INFORMATION FOR THE CITY OF GENEVA
 Time zone: CEST
 Emergency numbers: 117 for the
police, 144 for an ambulance
and 118 for the fire department
 Currency: Swiss franc | many
hotels, large restaurants and
shops accept euros

 Tourist information:
www.myswitzerland.com
 Swiss Federal Foreign Office:
www.auswaertiges-amt.de/en
 Credit cards: VISA, Mastercard
and American Express are
widely accepted. 

ADDITIONAL INFORMATION FOR THE EAO CONGRESS
 Venue address: Palexpo, Route
François-Peyrot 30, 1218, GrandSaconnex
 Event organiser: European Association for Osseointegration
 Coronavirus measures: Please
check foph-coronavirus.ch for
the most current information.

The EAO congress organisers
will make sure that the following measures are put in place
for the safety of all participants:
distribution of face masks, social
distancing of staff members, a
free testing centre and hand sanitiser stations. 

AD

REGISTER FOR FREE
DT Study Club – e-learning community

THE GLOBAL DENTAL CE COMMUNITY

THE GLOBAL DENTAL CE COMMUNITY

THE GLOBAL DENTAL CE COMMUNITY

THE GLOBAL DENTAL CE COMMUNITY

THE GLOBAL DENTAL CE COMMUNITY

Dentistry's largest online education community
webinars / live operations / online CE events / CE credits
www.dtstudyclub.com

@DTStudyClub

Tribune Group is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between
Tribune Group and Dental Tribune Int. GmbH.

[28] =>

floor plan

Floor plan Floor plan
Brieﬁng
rooms

Brieﬁng
rooms

Room Geneva

Speakers
service
centre

Speakers
service
centre

Room Geneva

H1
A2

B1

B2

A4

B1

B2

A4

Members
lounge

A6

C1

B5

A8

A8

D1

C7

B8
B9

B5

D2

Members
lounge

A2

A6

D2

C1

H1E1

C7

B9

H5

H5

H7

Hospitality
suite

C11
A14
E21

A24

A14

H19
A26

Hospit
suit

H19
B19

B19

Hospit
suit

H7
G10

E7

E29

D29

C29

E21

Hospit
suit

G6

G10

E7

G6

G1

C11

Hospitality
G1
suite

G2

D1

E1 B8

G2

F29

G30

H29

Hospit
suit

F30 G29

E30

E33

A28

Hospitality
suite

D34

A24

G30
A34

A44

E33

E37
SWISS
ASSOCIATIONS

A44

EAO

B43

B47

G40

Hospitality
G44
suite

F30 G29
D43

C47

Entrance

C48

D47

D48 E47

B52

SWISS
ASSOCIATIONS

C48

D47

D48 E47

C52

D51

B54 F35C51

F38 G37
C52

D51

D50 E49

C55
D67

D68 E67

D69

C68

NATIONAL SOCIETIES CORNER

I1

I2

I3

I4

D67

F47

H31

G44

H35

G47

C68

D68 E67

D69

F59

F60 G59
ePosters

F50 G49
I1

F59

E64 F63

I2

I3

G46

F64 G63

G48

E64 F63

H37

H50

ePosters

I4

H48

F60 G59
Committee
rooms

G46

F64 G63

G48

H37

H50

ePosters

= Diamond sponsors

29 th EAO Annual Scientific Meeting · Geneva

H48

presentations

Committee
rooms

28

ePoste

F50 G49

G40

D60 E59

C55

D50 E49

D60 E59

H35

G47

F47

B52

NATIONAL SOCIETIES CORNER

C51

H31

presenta

D43

B54

Entrance

D37

F38 G37

E30
C47

D34
B47

EAO

F29

B43

A28

A34

F35

E29

D29

C29

A26

E37 H29

D37

= Diamond sp

[29] =>

exhibitors

ListList
ofList
exhibitors
of exhibitors
of exhibitors

(as of 29(as
August
of 29(as
2022)
August
of 29 2022)
August 2022)

Patent
ZirconPatent
ZirconPatent
- F29Zircon - F29
G2
G2
Medical LTD Medical LTD Medical LTD

F29

American Dental
Systems
American
Dental
American
Systems
DentalG37
Systems
G30
E37 instruments
E37
G37
G30
G37
G30
HuFriedyGroup
HuFriedyGroup
Penguin
Penguin
instruments
Penguin
instruments
HuFriedyGroup
GmbH
GmbH
GmbH

E37

H31
E21
F60 Navigation
F60 Navigation
H31Navigation
F60
H31
Image
Planmeca
OyPlanmeca
OyPlanmeca
SRL
Implants SRL
Image
Aon ImplantsAon
SRLImplantsAon
Image
Oy

E21

E21

A4
H37 Co., Ltd.
H37
A4
Plasmapp
Co.,
Plasmapp
Ltd.
Co.,
Ltd.
Plasmapp

H37

D50

Datum Dental

Demirtaş Diş Deposu
San Tic. Ltd. Şti.

E49

ClaroNav

B5

F30

BTI

DGI - Deutsche
DGI - Deutsche
DGI - Deutsche
I1
Gesellschaft für
Gesellschaft
für NSK
I1
Gesellschaft für
Implantologie
Implantologie
Implantologie

D34 AG Medical
F30
F30
D34
Thommen
Medical
Thommen
AG Medical
Thommen
AG

DIO

DIO

DIO B2

D29 Core Academy
F64
F64
D29 group Total
B2
B2
D29 Core Academy
Nucleoss
Total
Nucleoss
group
Nucleoss
group
Total
Core Academy

Dr-Kim Co.

Dr-Kim Co.

D68Co.
Dr-Kim

E67
D68 College of
D68
E67 AG
NYU
College of Dentistry
Trate
NYU
Dentistry
NYU
College of
Dentistry

E67 AG
Trate

H29

H29

ÖGI - Österreichische
ÖGI - Österreichische
ÖGI - Österreichische
I2 Dental Implants
Gesellschaft
für TRI
B1
B1
I2
G48
G48
für
G48
I2 Dental Implants
Gesellschaft
für
TRI
Edra Publishing
Edra
Publishing Gesellschaft
Edra Publishing
TRI Dental
Implants
Implantologie
Implantologie
Implantologie

B1

Electro E.M.S
Medical
Electro Medical
E.M.S Electro E.M.S
Medical
F63
C47 Laboratoires
C47 Laboratoires
C47
F63
O.S.T
Laboratoires
Versah
O.S.T
O.S.T
System SA System SA System SA

E59

E59

F63
Versah

H29
Trate
AG

E59
Versah

EthOss

EthOss

G44
EthOss

B47 Dentalwerk
D43
B47 ImplantW&H
G44
G44
B47 Dentalwerk
Osstem
W&H
Osstem
Implant
Osstem
Implant
W&H
DentalwerkD43

D43

Euronda

Euronda

H09
Euronda

G40
G6
G6
G40 by Tecnoss
H09
H09
G40
Osteobiol
Woodpecker
Woodpecker
Medical
Medical
Osteobiol
by Tecnoss
Osteobiol
by Tecnoss
Woodpecker
Medical

G6

D67
F50
D67
F50
F50
F50 GmbH Osteogene
D67
Osteogene
TechZ-Systems
AGZ-Systems
AGZ-Systems
Tech
Exocad GmbH
Exocad
Exocad GmbH
Osteogene
Tech
AG

F50

D48 Dental Solutions
C48
D48
B9
B9
D48 Dental Solutions
Osteogenics
Biomedical
Zest
Zest
Osteogenics
Biomedical
Osteogenics
Biomedical
ZestC48
Dental Solutions

C48

C72 Foundation
H48
H48
H48
C72
Osteology
Zibone
Foundation
Gaba Suisse SA
Gaba
Suisse SA Osteology
Gaba Suisse SA
Osteology
Foundation

C72
Zibone

B54
Zibone

E7 Implant Oxy
E7 Implant OxyG49
E7 Biomaterials
Implant
Oxy
Geistlich Biomaterials
Geistlich
Geistlich Biomaterials

G49
ZimVie

H19
ZimVie

B54

B54

H19

H19

H19

G30

G10

G6

29 th EAO Annual Scientific Meeting · Geneva

D1

Straumann Group

H31

H29

H7

G49
ZimVie

Hospitality
suite

F50

Hospitality
suite

B9 D.O.O.
Fotona D.O.O.Fotona D.O.O.Fotona

D51

F64

29

G40

A8
A8
Surgident
CoSurgident
Ltd.
CoSurgident
Ltd.B5
Co Ltd.B5

Dentalk

D1

C68

NSKD34

Nibec co., Ltd.

MIS
G1

I4

C29
C68
C68
C29
G1 Biocare
G1
G1 Sirona Nobel
C29 AG
Biocare
Sweden&Martina
Sweden&Martina
Services
AGNobel
Dentsply Sirona
Dentsply
Dentsply Sirona
Nobel
Biocare
Services
AG Services
Sweden&Martina

I1
NSK

E49

Meisinger Group

Carestream Dental

BresMedical Pty Ltd

D51
D1
D51
Straumann
Group
Straumann
Group
Straumann
GroupD1

A24

E49

Curaden AG

G10

D2

A14

H5

E49
Stoma

F50

Lyra etk

E29

H7

E1

NikeA8
SRL

C55
Stoma

Botiss biomaterials GmbH

E47 SRL
Nike

Biotech Dental

E47 SRL
Nike

BioHorizons Camlog

E47Tech
Dental Tech Dental Tech Dental

C55
Stoma

Bluem International

Ivory Graft

IRES SAGL

H50

C55
Neoss
Ltd.

D51
A28 co., Ltd.Nibec
A28 co., Ltd.Nibec
co., Ltd.
Nibec

A28
Dentalk

Bien-Air Dental SA

Dentalk

Augma Biomaterials

Dentalk

D50 Ltd.
Neoss

Bionnovation Biomedical

F38

F35

E33

F60

Deposu
Demirtaş Diş Demirtaş
Deposu DişDemirtaş
D50 Ltd.
D50 Diş Deposu
Neoss
San Tic. Ltd. Şti.
San Tic. Ltd. Şti.
San Tic. Ltd. Şti.

SPEMD - Sociedade
SPEMD - Sociedade
SPEMD - Sociedade
G1
I4
I4
G1
Portuguesa
dePortuguesa
Estomatologia
dePortuguesa
Estomatologia
de Estomatologia
e Medicina Dentária
e Medicina Dentária
e Medicina Dentária

MIS G1

G1
MIS

C11

Infodent

A24 AG
Curaden AG Curaden AG Curaden

CleanImplant Foundation

E30

D37
G47
F50
F50
D37 Implant
F50
D37
MegaGen
SigmaGraft
SigmaGraft
Foundation
Foundation
MegaGen
Implant
CleanImplantCleanImplant
Foundation CleanImplant
MegaGen
Implant
SigmaGraft

MedPark

B19
E30 Implants
E30
A24
A24
B19 GroupSouthern
B19
Meisinger
Implants
Southern
Implants
Meisinger
Group
Meisinger
Group
Southern

Mectron SPA

G47

Lupenbrillen 24

G47

C52
MedPark

G10
MedPark

A28

C52

B52

Medentis medical GmbH

Keystone Dental Group

G29

G1
G1 Dental MIS
Datum Dental
Datum
Datum Dental

3D Totem

C52Invent AGSIC G29
C52Invent AGSIC
SIC
Invent AG

I3

G29

G10
MedPark

JDentalCare Srl

Industrie Biomediche
Insubri (IBI) SA

G10
ClaroNav

ImplantStock

ClaroNav

Image Navigation

HuFriedyGroup

Global D

ClaroNav

F59

C55

B43

G46

A2

SDS
SDS
SDSF59
Swiss DentalF59
B43 Swiss Dental
B43 Swiss Dental
Solutions AG Solutions AG Solutions AG

C51

A14
A14
B43 SPA
Mectron
SPA Mectron
SPA Mectron

Stoma

C1

F47

D60

D47

C7

A6

BTI A14

G59

BTI

A4

H31

G30

BTI

G47

G29

C51 Implant S.I.N
C1
C1
C51 Implant S.I.N
S.I.N
System
System
Implant System

SigmaGraft

LyraC51
etk

G63

D37

E29 etk
Lyra

G63

MegaGen Implant

E29
E29
Botiss GmbH
biomaterials
Botiss
GmbH
biomaterials
Lyra
GmbH
etk
Botiss biomaterials

A44

Neoss Ltd.

SDS Swiss Dental
Solutions AG

Saeyang Co., LTD.

Rhein 83 S.R.L.

Regedent AG

Quest Implants

Purgo Biologics

Plasmapp Co., Ltd.

Planmeca Oy

F47 83 S.R.L.
G63
H7
H7GroupDental
F47
H7 International
F47
Keystone
Group83 S.R.L.
Rhein
Bluem International
Bluem
Keystone
Dental
Bluem International
Keystone
GroupDentalRhein
Rhein
83 S.R.L.

A44

SIC Invent AG

SEPA - Sociedad Española
de Periodoncia
y Osteointegración

I3

F59

A2

S.I.N Implant System

C1

G63

A44

A34
Quintessence Publishing

Power Dental USA Inc.

Penguin instruments

D69

H35

H1

H37

A34

E21

D47
A34
A34
D47
Quintessence
Quintessence
Publishing Quintessence
Publishing
Publishing

E37

D47
Ivory
Graft

H5

Diamond
onsors =sponsors
Diamond sponsors

H50 Graft
Ivory

G2

H50

D69

Hospitality
suite

H50
37

H48

C7 Implants
D69
C7 Implants
Quest
Quest
Quest
Implants D69

H1

H48

IRESC7
SAGL

SEPA - Sociedad
SEPA
Española
- Sociedad
Española
SEPA
- Sociedad Española
B52
I3
I3
B52
D2
D2 GmbH
D2
B52
de
Periodoncia
de
Periodoncia
de Periodoncia
Medentis
medical
GmbH
Medentis
medical
Carestream Dental
Carestream
Dental
Carestream Dental
Medentis
medical
GmbH
y Osteointegración
y Osteointegración
y Osteointegración

ers
ePosters
ePosters

tions
presentations
presentations

C11 SAGL
IRES

Aseptico, Inc

35

C11 SAGL
C11
BioHorizons Camlog
BioHorizons
Camlog
IRES
BioHorizons Camlog

Aon Implants SRL

31

H35

G46
A2 Co., LTD. A2
H5
H5
H5
G46
Lupenbrillen
24 Saeyang
Co., LTD.
Saeyang
Co., LTD.
BresMedical
Pty
BresMedical
Ltd
Pty Lupenbrillen
Ltd
24
BresMedical Pty
Ltd
Lupenbrillen
24 G46
Saeyang

B8

ality
Hospitality
Hospitality
te suite suite

A6 Biologics
H35Biologics H35
A6 Biologics
Purgo
Purgo
Purgo

D60
A44 AG
E1
E1
D60
E1 Dental JDentalCare
D60
JDentalCare
Srl Regedent
AGRegedent
AGRegedent
Biotech Dental
Biotech
Srl
Biotech Dental
JDentalCare
Srl

ality
Hospitality
Hospitality
te suite suite

29

A6
Infodent

G37

List of exhibitors

ality
Hospitality
Hospitality
te suite suite

F38
Infodent

American Dental Systems
GmbH

H7

H1

F38
F38 Dental SA
Infodent
Bien-Air
Dental
Bien-Air
SA
Bien-Air Dental
SA

H50 Graft
H50
Biomedical
Biomedical
Ivory
BionnovationBionnovation
Biomedical Bionnovation

Patent Zircon Medical LTD

H5

(as of 29 August 2022)

1

G2

ality
Hospitality
Hospitality
te suite suite

F29

Industrie
Industrie
Biomediche
Industrie
Biomediche
G59
F35
F35
G59 Biomediche
F35 Biomaterials
G59 DentalPower
Power
USA Inc.
DentalPower
USAH1
Inc.
Augma Biomaterials
Augma
Augma Biomaterials
Dental USAH1
Inc.
Insubri (IBI) SA
Insubri (IBI) SA
Insubri (IBI) SA

I4

E33
E33
A4
ImplantStock
ImplantStock
ImplantStock

SPEMD - Sociedade
Portuguesa de Estomatologia
e Medicina Dentária

G2D
Global

G1

B8
Global
D

E30

E33 Inc
Aseptico, Inc Aseptico, Inc Aseptico,

B8 D
Global

Southern Implants

B8
3D Totem

B19

3D Totem

Hospitality
suite

3D Totem

[30] =>

travel

What’s on in Geneva
Ten brilliant things to do in the city during EAO 2022 from 29 September to 1 October
Old Town of Geneva © Michal Ludwiczak

not sound like fun, then hop on a
cable car to reach the peak in just
5 minutes, where cafes also await
visitors.

Bring a raincoat
for Jet d’Eau!
A very interactive landmark, the
high pressure geyser found at the
end of a jetty has brought delight to
Geneva since 1886. The high-pressure
spray reaches 140 m in height, and
at 500 l of water each second, there’s
no guaranteeing onlookers will stay
dry.

Take a dip at Bains des Pâquis
Whatever the weather, enjoying the
water at Bains des Pâquis is a must-do
experience. In colder weather, warm up
afterwards in the sauna and hammam,
and in warmer seasons, take time to sunbathe after a filling lunch at the nearby
restaurant. If water isn’t your thing, the
location also hosts morning recitals of
both classical music and poetry.

Take to the water at Lake Geneva

Get a little exercise in
at Mont Salève

Explore your artistic side
in the Bains District

Whether you’re up for a little
hiking or prefer more intense activities like mountain biking or even
paragliding, the views at Mont Salève
are unparalleled. If 1,400 m does

The Quartier des Bains has twelve
galleries, hosts frequent events and
is a hub for night life. Consequently,
it is the perfect zone for art lovers.

Geneva was designed around the
curves and beauty of its lake. In addition
to visiting breathtaking promenades
and parks such as the Jardin Anglais or

Take part in a tour of the
legendary facility that breaks
science down into layman’s terms, and
then explore the various museum
exhibitions which explain how the
work of the European Organization for
Nuclear Research is benefiting modern medicine and science. Visitors
can also dive into the mysteries of the
Higgs boson.

29 th EAO Annual Scientific Meeting · Geneva

Explore the Reformation

Go ahead and smell the roses!
Your nose will be quite busy if you
journey to the city’s botanical gardens.
There are more than 14,000 species on
hand inside the arboretum, around the
ponds, in the greenhouse and in flower-

Adjacent to the Cathedral of St Pierre,
the spiritual home of John Calvin in Geneva,
is the International Museum of the Reformation, a highlight for history buffs.
The museum provides a powerful view of
the Reformation and displays paintings, engravings and very early printed materials.
The museum also offers a brief 15-minute
video outlining the Reformation. This historic dwelling was built during the eighteenth century on the former site of the cathedral cloisters where the vote to approve
the Reformation took place in 1536. 

Satisfy your inner nerd
at CERN

beds, and the gardens are a hub for botanists. The attached zoo features waterfowl and deer and has an emphasis on
conservation. Schedule your trip for after your visit to the Palais des Nations, as
it is right across the railway tracks.

Take a break between galleries at any
one of the fun bars or bistros, and be
sure to check out the famous MAMCO,
Musée d’art moderne et contemporain,
and CAC, Centre d’Art Contemporain.
Three times a year, La Nuit des Bains,
a special art discovery event,
takes place. So venture off Plainpalais to this artistic wonderland.

Switzerland’s largest historical
city, the Old Town in Geneva, is filled
with ancient marble fountains and
world-famous cafes like La Clémence,
Café du Bourg-de-Four and Au Carnivore.
For history enthusiasts, the museum
Maison Tavel recounts the city’s history, and in the Old Arsenal, behind
some massive cannons, three frescoes
portray key moments in Geneva’s
history, including the arrival of Julius
Caesar in the city in 58 BC.

Mon Repos, consider taking a boat from
Genève-Mont-Blanc for a trip to another
part of the city, or even travel all the way
to Lausanne, a three-hour trip.
CERN © Edong liu/Shutterstock.com

Head to the Old Town
for a unique vista

Take one of the offered one-hour
guided tours at the Palais des Nations,
a key UN landmark. The available tour
locations are ever-changing, but range
from the Council Chamber, the Salle
des Pas Perdus, the Assembly Hall,
and the famed Human Rights and
Alliance of Civilizations Room.

Fancy a little diplomacy?

[31] =>

Straumann Corporate Forum:

Digital immediacy in your daily practice

V I SIT US A
BOOTH D1T

September 29 | 16:30 – 18:30 | Room C
Eirik Salvesen will chair this session with Maja Chmielewska, Abid Faqir
and Panagiotis Papaspyridakos on successful immediate treatment
concepts for different reconstruction modalities, from single-tooth
restoration to full-arch rehabilitation, with particular attention to
planning and component selection based on the patients’ unique
needs.

Prof. Eirik

SALVESEN

Prof. Maja

CHMIELEWSKA

Prof. Abid

FAQIR

Prof. Panagiotis

PAPASPYRIDAKOS

Chair

Straumann® TLX Implant System

Iconic Tissue Level meets
Immediacy.

DESIGNED FOR
IMMEDIATE PROTOCOLS

PERI-IMPLANT HEALTH
PRESERVATION

SIMPLICITY
AND EFFICIENCY

Fully tapered implant design for
optimized primary stability.

Reduced risk of nesting bacteria and
optimized cleansability.

One-stage process with restoration
at soft-tissue level allows to use chair
time more efficiently.

The design of the Straumann® TLX Implant takes into account key biological principles of hard and soft tissue healing.
It is designed to significantly reduce the risk of inflammation and bone resorption as the implant-abutment interface is
moved away from the bone. Contact your local Straumann representative now or visit www.straumann.com/tlx
References on www.straumann.com/tlx

[32] =>

TRULY CONICAL PRECISION

CONELOG®
PROGRESSIVE-LINE
conical performance 1,2
at bone level

Precise conical connection
long conus for reduced micromovements
superior positional stability in comparison
to other conical systems 1,2
easy positioning with excellent tactile feedback

M-1441-ADV-EN-GLO-BHCL-00-052022

integrated platform switching supporting the
preservation of crestal bone

[1] Semper-Hogg, W, Kraft, S, Stiller, S et al. Analytical and experimental position stability
of the abutment in different dental implant systems with a conical implant–abutment
connection Clin Oral Invest (2013) 17: 1017
[2] Semper Hogg W, Zulauf K, Mehrhof J, Nelson K. The influence of torque
tightening on the position stability of the abutment in conical implant-abutment
connections. Int J Prosthodont 2015;28:538-41

www.biohorizonscamlog.com

Visit us at
our Booth C11
and sign up for:
Hands-on-workshops
and lectures !

) [page_count] => 32 [pdf_ping_data] => Array ( [page_count] => 32 [format] => PDF [width] => 846 [height] => 1187 [colorspace] => COLORSPACE_UNDEFINED ) [linked_companies] => Array ( [ids] => Array ( ) ) [cover_url] => [cover_three] =>

[cover] => today EAO Annual Scientific Meeting Geneva Sept. 29–Oct. 1, 2022

[toc] => Array ( [0] => Array ( [title] => EAO congress makes comeback in novel hybrid format [page] => 1 ) [1] => Array ( [title] => BioHorizons Camlog organises comprehensive educational programme for EAO 2022 congress attendees [page] => 1 ) [2] => Array ( [title] => “We are planning to make quite an impact at the EAO congress” [page] => 1 ) [3] => Array ( [title] => First hybrid edition of EAO congress is critically evaluating technological developments in dentistry [page] => 4 ) [4] => Array ( [title] => News [page] => 6 ) [5] => Array ( [title] => Interview: “Innovation in education and enablement is a continuous journey” [page] => 8 ) [6] => Array ( [title] => Interview: CleanImplant Foundation: Greater safety in implantology and a stage for quality manufacturers [page] => 10 ) [7] => Array ( [title] => Interview: “Clinicians buy too many products and cannot necessarily make use of all of them” [page] => 12 ) [8] => Array ( [title] => News [page] => 13 ) [9] => Array ( [title] => Interview: “At Neoss, we have the luxury of being able to be more forward-oriented” [page] => 16 ) [10] => Array ( [title] => News [page] => 18 ) [11] => Array ( [title] => Industry [page] => 22 ) [12] => Array ( [title] => Floor plan [page] => 28 ) [13] => Array ( [title] => Exhibitors [page] => 29 ) [14] => Array ( [title] => Travel [page] => 30 ) ) [toc_html] =>

Table of contents

[toc_titles] =>

[cached] => true )